|
Selenium may be very important in human nutrition because this mineral
may aid in preventing some cancers.
FUNCTIONS
Selenium
is a component of one form of an important enzyme called glutathione peroxidase.
This enzyme exists in fluid in and around all body cells and it inactivates
substances called peroxides, which contain high level of oxygen. Since
excess oxygen can be toxic to body cells and cause tissue destruction,
peroxide pose a treat to vital tissues and membranes, causing cancer or
even death.
Glutathione
peroxidase is thought to be our first line of defense against peroxidase
damage. Vitamin E, located inside cell membranes, is a second line of
defense against peroxide. Thus, selenium and vitamin E go hand in hand
in their protective role for body tissue.
DAILY
REQUIREMENTS
Human selenium
requirements are not known with certainty. An estimated safe and adequate
daily selenium intake is between 50 and 200 mcg. Since our daily requirement
is not known and many vitamin/mineral supplements do not contain selenium,
we are faced with a difficult challenge when it comes to choosing a selenium
supplement. Because of possible toxicity concerns, you should keep your
daily intake below 100 mcg. This, together with the selenium in your food,
should be ample.
DIETARY
SOURCES
The selenium
content of food is highly variable because of the wide variability in
selenium concentrations in the soil in which foods are grown. Seafoods,
organ meats, and whole grains are considered to be good sources of selenium.
Fruits and vegetables are considered to be selenium-poor. Food - refining
processes, cooking, and discarding the water in which foods are cooked
all contribute to our difficulty in getting enough selenium in our diet.
Dietary
surveys indicate that daily average intake various from 50 to 150 mg a
day.
DEFICIENCIES
Selenium
deficiency has been well documented and studied livestock and lab animals.
Animal deficiencies cause a variety of serious and life-threatening conditions,
including infertility, muscular dystrophy, exudative diathesis in fowl,
pancreatic fibrosis in chicks, hepatosis in pigs, and unthrifitness or
sickliness in cattle and sheep. These deficient states are much the same
as those associated with vitamin E deficiency, and large doses of selenium
will cure most, but not all, vitamin E deficiency symptoms. Since both
selenium and vitamin E play a role in protecting against oxidative damage,
it is not surprising that one cn sometimes be substituted for the other.
Human selenium
deficiency is almost unknown, even in areas of the country where livestock
suffer selenium deficiency. Selenium deficiency has, however, been seen
in a few people with alcoholic cirrhosis and a few people receiving long-term
intravenous feeding without added selenium. They suffered from heart problems
that responded to selenium supplements. There is also speculation that
Keshan's disease, a fatal heart disease seen in children living in certain
sections of China, may be related to selenium deficiency.
TOXICITY
Selenium
toxicity in animals can lead to blindness, excess salivation, paralysis,
and difficulty breathing. Interestingly, human selenium poisoning has
not been reported to come from foods grown in the same areas where livestock
are being poisoned by selenium. Selenium poisoning has, however, been
reported in several Chinese villages where drought forced villagers to
eat vegetables high in selenium. In these villages, daily intakes were
found to be 3,000 to 7,000 mcg a day. Villagers suffered hair and mail
loss and nervous system problems.
Epidemiological
studies have also demonstrated a relation ship between high selenium concentrations
in water and dental cavities.
THERAPEUTIC
USES
Animal studies
have conclusively demonstrated that selenium deficiencies increase the
number and growth rate of tumors when cancer-causing chemicals are administered.
High selenium intake seems to exert a protective effect in these studies.
Since the selenium-dependent enzyme gluathione peroxidase protects against
cellular peroxidase damage, as discussed under "Function," it
seems reasonable to assume peroxidase damage is somehow related to cancer.
The only
evidence that selenium may protect against tumors in man is obtained from
broad-based epidemiological studies. If one compares the selenium content
of drinking water with cancer death rates in various parts of the country,
or even between countries, one finds the following relationship : Higher
selenium levels are associated with a lower cancer rate. Other factors
obviously enter into this and cancer is still a problem in high selenium
areas. It has been estimated that the risk for some cancers is twice as
high in low-selenium areas than in high-selenium areas. High selenium
concentrations can be found in parts of Wyoming, Alaska, Arkansas, Mississippi,
South Dakota, and Colorado. Low selenium concentrations can be found in
California, Ohio, Washington, Oregon, Pennsylvania, Indiana, and New York,
Breast, colon, and lung cancers, our biggest killers, seem to be affected
by selenium intake.
Zinc, cadmium, and copper counteract the effects of selenium in the body,
and high intakes of these minerals may even counter the cancer-protective
effects of selenium, though there are no human studies to support this
claim. We believe it is better to take a mineral mixture balanced by Mother
Nature - that is, the kind found in whole grains and seafood - than to
fool with potent mineral supplements, at least until more is known.
The associated
of selenium deficiency with heart problems in humans has created interest
in the therapeutic benefit of selenium supplements in heart disease. The
answer to this proposition is not yet in.
UNSUBSTANTIATED
CLAIMS
Selenium,
like manganese, has been erroneously promoted for an antiaging effect
because of its role in controlling oxygen levels. Other unsubstantiated
claims include detoxifying heavy metals, drugs, alcohol, and cigarette
smoke; improving skin problems; increasing male potency and sex drive;
and arthritis treatment.
AVAILABILITY
Some vitamin/mineral
supplement formulas contain selenium, and it is also available in tablet
form.
BONE
SCAN
BACK
Test Overview
Nuclear scanning
tests use a special camera to take pictures of certain tissues in the
body after a radioactive tracer accumulates in the tissues to make them
visible. Each type of tissue that may be scanned uses a different radioactive
compound as a tracer. The tracer remains in the body temporarily before
it is eliminated as waste, usually in the urine or stool.
For a bone
scan, the tracer (radioactive technetium disphosphonate) is injected into
a vein in the arm. The tracer then travels through the blood stream and
into the bones. Areas of rapid bone growth of repair absorb increased
amounts of the tracer show up as bright or "hot" sports in the
pictures. Hot spots may indicate the presence of a tumor, a fracture,
or an infection. Areas where little or no tracer is absorbed appear as
dark or "cold" spots, which may indicate a lack of blood supply
to the bone or the presence of a certain types of cancer.
Bone scans
are used to evaluate damage to the bones, to detect cancer that has spread
to the bones, and to monitor conditions that can affect the bones. A bone
scan can often detect a problem months earlier than a regular X-ray test.
This test
may be done on the entire body or just a part of it.
Why it
is Done
A bone scan
is done to :
- Determine
whether a cancer from another area (such as the breast, lung, kidney,
thyroid gland or prostate gland) has spread (metastasized) to the bone.
- Help diagnose
the cause of unexplained bone pain.
- Help diagnose
broken bones not clearly evident on X-ray
- Detect
damage to the bones caused by infection or other conditions.
How to
Prepare
Before the
bone scan, tell your doctor if :
- You might
be pregnant.
- You are
breast-feeding.
- Within
the past 4 days, you have had an X-ray test using barium contrast material
or have taken a medication that contains bismuth. Barium and bismuth
can interfere with test results.
You usually
have to wait 1 to 3 hours after the radioactive tracer is injected before
your bone scan is done. Therefore, you may want to bring some reading
materials or items for another project to pass the time during this waiting
period. For some types of bone scans, pictures are taken during the tracer
injection, immediately afterward, and then 3 to 5 hours after the injection.
No other
special preparations are needed before having a bone scan.
You should empty your bladder just before the test begins.
How it
is Done
A bone scan
is usually done by a radiology or nuclear medicine technologist. The resulting
pictures are usually interpreted by a doctor who specializes in evaluation
nuclear scanning tests (radiologist or nuclear medicine physician).
You will
need to remove any jewelry that might interfere with the scan. You may
need to take off all or most of your clothes, depending on which area
is being examined. You will be given a cloth or paper covering to use
during the test.
The technologist
cleans the site on you arm where the radioactive tracer will be injected.
An elastic band is then wrapped around your upper arm to temporarily stop
the flow of the blood through the veins in your arm. This makes it easier
put the needle into a vein properly because the veins below the band get
larger and do not collapse easily. A small amount of the radioactive tracer
is then injected, usually into a vein on the inside of your elbow.
It takes
1 to 3 hours for the tracer to distribute throughout your body. During
this time you may be asked to drink 4 to 6 glasses of water to help eliminate
any of the radioactive substance that does not collect in your bones.
Just before the scan begins, you will usually be asked to empty your bladder
to prevent any radioactive urine from blocking the view of your pelvic
bones during the scan.
During the
scan, you will lie on your back on a table and the scanning camera will
be positioned closely above you. It may move slowly above and around your
body, scanning for radiation released by the tracer and producing pictures
of the tracer's distribution in your bones. The camera does not produce
any radiation, so you are not exposed to any additional radiation while
the scan is being done. You may be asked to move into different positions
so the area of interest can be viewed from other angles. You need to lie
very still during each scan to avoid blurring the pictures.
The scan
takes about an hour.
How it
feels
You may feel
nothing at all from the needle puncture when the tracer is injected, or
you may feel a brief sting or pinch as the needle goes through the skin.
Otherwise, a bone scan is painless. You may find it uncomfortable to remain
still in different positions during the scan. Ask for a pillow or blanket
to make yourself as comfortable as possible before the scan begins.
Risks
There is
always a slight risk of damage to cells or tissue from being exposed to
any radiation, including the low level of radiation released by the radioactive
tracer used for this test. However, if this test is really needed, the
risk of damage from the tracer is usually very low compared with the potential
benefits of the test. Most of the tracer will be eliminated from your
body within a day. Allergic reactions to the tracer are very rare.
Occasionally,
some soreness or swelling may develop at the site where the radioactive
tracer was injected. These symptoms can usually be relieved by applying
moist, warm compresses to your arm.
Results
The results
of a bone scan are usually available within 2 days.
Bone Scan
Normal : The radioactive tracer is evenly distributed among the
bones. No areas of abnormally high or low accumulation are seen.
Abnormal
: The tracer may accumulate in certain areas of the bone, indicating
one or more hot sports. Hot spots may be caused by a fracture that is
healing, bone cancer, a bone infection (osteomyelitis), arthritis, or
a disease of abnormal bone metabolism (such as Paget's disease).
Certain
areas of the bone may lack the presence of radioactive tracer, indicating
one or more cold spots. Cold spots may be caused by a certain type of
cancer (such as multiple myeloma) or lack of blood supply to the bone
(bone infarction).
What affects
the test
- A bone
scan is not usually done for a pregnant woman because the radiation
could damage the developing fetus.
- Barium
and bismuth can interfere with test results. If a bone scan is needed,
it should be done before any tests that use barium (such as a barium
enema).
- The results
of a bone scan may not be accurate if the person cannot remain still
during the test.
- A full
bladder can block the view of the pelvic blocks.
What to
think about
- A bone
scan does not distinguish between normal and abnormal bone growth. Therefore,
bone scan results must be interpreted along with the results of X-ray
tests. In addition, other tests (such as magnetic resonance imaging,
MRI) may also be needed to further evaluate abnormal bone scan results.
For more information, see the following medical tests :
- Chest
X-ray
- Extremity X-ray
- Spinal X-ray
- Magnetic Resonance imaging (MRI) of the Body
- Magnetic Resonance imaging (MRI) of the spine
- A woman
who is breast -feeding and has a bone scan should ask her doctor whether
she needs to wait for a period of time before she resumes breast-feeding
her child.
DIABETES
BACK
What is
Diabetes?
When you
or someone you love has diabetes, you discover that you must think about
a part of life that others take for granted. Your never-changing goal
becomes reaching a subtle balance between glucose and insulin. The more
learn about diabetes, the better you can be at your balancing act, and
the richer your life shared with this chronic disease can be.
TYPES
OF DIABETES
Diabetes
refers to a set of several different diseases. The most common types of
diabetes are type 1, or immune-mediated diabetes mellitus, and type 2,
or insulin - resistant diabetes mellitus. A third type of diabetes, gestational
diabetes mellitus, occurs during some pregnancies.
All types
of diabetes have similar symptoms, because all forms of the disease result
in too much sugar, or glucose, in the blood. This is because your body
is unable to remove glucose from your blood and deliver in to the cells
in your body. Your cells use glucose as a source of energy in order to
say alive. But the reasons why your body cannot use glucose from the blood
are different for type 1 and type 2 diabetes.
People with
type 1 diabetes do not make enough insulin. Insulin is a small protein
made by the pancreas that helps the body use or store glucose from food.
People with type 1 diabetes can be treated with injections of insulin.
In contrast, people with type 2 diabetes, like women with gestational
diabetes, do make insulin, but for some reason, the cells in their bodies
are resistant to insulin's action or they don't make enough insulin. In
all types of diabetes, if glucose does not get into the cells and tissues
that need it, it accumulates in the blood.
About half
of all cases of type 1 diabetes appear in childhood or in the early teenage
years. For this reason, it used to be called juvenile-onset diabetes.
If your symptoms first appeared during the early teenage years, your doctor
probably suspected diabetes right away. If you were a young child when
the disease developed, it might have occurred so fast that you went into
a coma, before anyone suspected diabetes. Type 2 diabetes most often develops
in adulthood and used to be called adult-onset diabetes. Usually, it does
not appear suddenly. Instead, you may have no noticeable symptoms or only
mild symptoms for years before diabetes is detected, perhaps during a
routine exam or blood test. Gestational diabetes only appears during pregnancy
in women with no previous history of type 1 or type 2 diabetes and goes
away after pregnancy. Pregnant women are tested for gestational diabetes.
All people with diabetes have one thing in common. They have too much
sugar, or glucose, in their blood. People with very high or poorly controlled
blood glucose level share many similar symptoms.
- An unusual
thirst
- A frequent
desire to urinate
- Blurred
vision
- A feeling
of being tried most of the time for no apparent reason.
People with
type 2 diabetes may also experience leg pain that may indicate nerve damage
or poor circulation. Many people with type 1 diabetes and some people
with type 2 diabetes also find that they lose weight even though are hungrier
than usual and are eating more.
Even if
they have lost weight, people with type 2 diabetes still tend to be overweight.
Three-fourths of all people with type 2 diabetes are or have been obese
- that is, they are at least 20 percent over their desirable body weight.
Type 2 diabetes tends to develop in people who have extra body fat. Where
you carry your excess fat may determine whether you get type 2 diabetes:
Extra fat above the hips is riskier than fat in the hips and thighs for
developing for 2 diabetes. And leading an inactive "couch potato"
lifestyle can also leads to diabetes. It also contributes to obesity.
If you have
recently been diagnosed with diabetes, you are not alone. Nearly 16 million
Americans - about one of every 17 people - have the disease. About 1,800
new cases each year. Ninety to ninety-five percent of all cases of diabetes
in people over age 20 are type 2 diabetes. And half of all people with
type 2 diabetes are unaware they even have the disease. Because of the
nature of type 2 diabetes, it is possible to have mild symptoms or signs
of type 2 diabetes for years before diabetes worsens. In contrast, few
cases of type 1 diabetes go undetected to long. The symptoms of type 1
diabetes are severe enough that the person goes to the doctor for help.
WHO HAS
DIABETES?
Almost 16
million Americans have diabetes. This is about 6 percent of the people
in the country. In 1999, it was estimated that 500,000 to 1 million people
had type 1 diabetes. It is hard to get an exact count of the number of
people with diabetes because we have no nationwide diabetes registry.
Slightly under half of the people with type 1 diabetes are children and
teenagers age 20 and younger. Type 1 diabetes is more common in whites
than in African Americans, Hispanic Americans, Asian Americans, and Native
Americans.
In 1999,
it was estimated that about 9.5 million people had diagnosed type 2 diabetes.
Another 5 to 6 million people are undiagnosed. It is common in older people.
Nearly 11 percent of Americans age 65 to 74 have type 2 diabetes. It is
more common in some ethnic groups than others. In American age 45 to 74,
over 14 percent of Mexican Americans and Puerto Rican Americans have type
2 diabetes, over 10 percent of African Americans have type 2 diabetes,
and about 6 percent of Cuban Americans and whites have type 2 diabetes.
Type 2 diabetes is even more common in Nature Americans: In some groups,
almost half of adults age 30 to 64 have type 2 diabetes.
About 135,000
women develop gestational diabetes each year. Of these, about 40 percent
get type 2 diabetes within 15 years.
TESTS
FOR DIABETES
Although
your physician may suspect that you have diabetes because of your symptoms,
the only sure way to tell is with blood tests. Blood tests are used to
diagnose both type 1 and type 2 diabetes, as well as gestational diabetes.
Your doctor may repeat your blood tests to be sure of the diagnosis.
The blood
tests are based on the fact that diabetes keeps your blood glucose, or
sugar, levels above normal some or all of the time. Your blood glucose
levels may be high even though you haven't eaten recently. In addition,
your body cannot get rid of the extra glucose that appears in the blood
after eating.
Random plasma
glucose tests are the simplest way to detect diabetes. This test measures
the amount of glucose in the blood at any given time and is done without
fasting. If you have obviously symptoms of diabetes and the amount of
glucose in your blood is 200 mg/dl or higher, your doctor will diagnose
diabetes. Symptoms of diabetes include frequent urination, intense thirst,
blurred vision, unexplained weight loss, and extreme tiredness.
The preferred
method for diagnosing diabetes is the fasting plasma glucose test. For
this test, your doctor will ask you not to eat for at least 8 to 10 hours.
Then, a sample of your blood is taken, and the amount of glucose present
in the blood is measured. Normally after fasting, the amount of glucose
is less than 126 mg/dl, the doctor will suspect diabetes. In diabetes,
extra glucose remains in the blood, even after fasting, because it cannot
enter the body's cells. This is due to a lack of insulin or resistance
to the action of insulin. Doctors usually make a firm diagnosis of diabetes
when two fasting plasma glucose tests, done on different days, are over
126 mg/dl.
If your
test results are greater than 110 mg/dl but less than 126
mg/dl, you may be diagnosed with impaired fasting glucose. This is not
diabetes, but sometimes occurs before diabetes, usually type 2 diabetes,
develops. Some people with impaired glucose tolerance nerve get diabetes.
However, some of the same problems that result from having diabetes also
occur in people with impaired glucose tolerance. If you have been diagnosed
with impaired glucose tolerance, your physician will want to watch carefully
for diabetes. Also, you need to talk with your doctor about reducing your
risk of heart disease, keeping your weight in the healthy range, and exercising
regularly to lower your chances of developing diabetes.
Not Sure Which Type of Diabetes You Have?
|
Your
characteristics
|
Do
I have type 1 diabetes?
|
Do
I have type 2 diabetes?
|
|
Age
10 at diagnosis
|
Probably
|
Not
likely
|
|
Age
20 at diagnosis
|
Probably
|
Not
likely
|
|
Age
30 at diagnosis
|
Probably
|
Not
likely
|
|
Age
40 at diagnosis
|
May
be
|
May
be
|
|
Age
50 at diagnosis
|
Not
likely
|
Probably
|
|
Age
60 at diagnosis
|
Not
likely
|
Probably
|
|
Age
70 at diagnosis
|
Not
likely
|
Probably
|
|
Under
weight at diagnosis
|
Probably
|
Not
likely
|
|
Normal
weight at diagnosis
|
May
be
|
May
be
|
|
Overweight
at diagnosis
|
Yes
|
May
be
|
|
Large
amount of ketones in urine from time to time
|
Yes
|
No
|
|
Family
history of type 1 diabetes
|
Yes
|
May
be
|
|
Family
history of type 2 diabetes
|
May
be
|
Yes
|
|
Previous
gestational diabetes
|
No
|
Yes
|
|
Use
insulin
|
Yes
|
Yes
|
|
Use
oral diabetes medication
|
Only
for the first few months, if at all
|
Yes
|
|
Use
no diabetes medication
|
No
|
Yes
|
Certain pregnant women with no history of diabetes are at high risk for
developing gestational diabetes. These are women who are 25 years of age
or older, are overweight, have a patient or sibling with diabetes, or
are Hispanic, Native American, Asian, or African-American.
If you have
nay of these characteristics, your obstetrician will screen you for gestational
diabetes with a glucose challenge. This is done between the 24th and 28th
weeks of pregnancy. At this time, the hormones of pregnancy naturally
begin to cause temporary insulin resistance that lasts until the baby
is born. The glucose challenge helps your doctor determine whether your
body is able to overcome the insulin resistance on its own. You are given
a glucose drink to finish at a certain time, without regard to eating.
If the glucose in your blood 1 hour later is 140 mg/dl or above, you may
have gestational diabetes. Your doctor will need to give you another test,
for which you may need to fast, for a firm diagnosis.
TYPE 1
OR TYPE 2?
If tests
reveal that you have diabetes, your doctor must then decide whether you
have type 1 or type 2 diabetes. Although the symptoms and blood test results
are similar for both type 1 and type 2 diabetes, the cause are very different.
DIABETES : FACT OR MYTH?
"I used to have type 2 diabetes, but now I have
type 1 diabetes. My doctor put me on insulin last year".
Lot of people, over 40 percent of adults with diabetes, use insulin.
But because there are about 90 adults with type 2 diabetes to every
5 adults with type 1 diabetes, this means there are a lot of people
with type 2 diabetes must use insulin to make up for their pancreas
no longer making it. You don't necessarily have type 1 diabetes just
because you have to take insulin. Many people with type 2 diabetes need
extra insulin to overcome their body's resistance to the insulin already
being made by the pancreas.
Type 1 diabetes and type 2 diabetes, while having a lot in common,
are two different disease. They have different causes. The type of diabetes
you have does not change as you age or if you lose or gain weight or
change treatment.
It will help your doctor to know whether there has been type 1 or type
2 diabetes in your family. Your age is not the only clue about what type
of diabetes you have. It's true that most people younger than age 20 who
show signs of diabetes have type 1 diabetes and that most people diagnosed
with diabetes when they're over age 30 have type 2 diabetes. But there
are exceptions. In some cases, families carry a genetic trait for developing
type 2 diabetes as young people. And in some Native American families,
obesity is so prevalent that children as young as 10 years old have type
2 diabetes.
If you are
overweight or obese, it is more likely that you have type 2 diabetes.
- If you
suddenly developed signs of diabetes, such as frequent urination, unusual
thirst and hunger, and weight loss, perhaps after an illness, and are
a young adult or child, it is more likely that you have type 1 diabetes.
- If you
are not overweight and there are ketones in your urine, it is more likely
that you have type 1 diabetes.
- If you
are African American or Hispanic American, are older than 50, are overweight,
and haven't been feeling quite "right" for along time, it
is more likely that you have type 2 diabetes.
- If your
doctor treats you with insulin injections, you could have either type
1 or type 2 diabetes.
WHO GETS DIABETES?
The risk
factors associated with type 1 or type 2 diabetes are different. For both
type 1 and type 2 diabetes, having a family hisotry of diabetes puts you
at a higher risk for developing the disease than for a person with no
family hisotry of diabetes. However, many people with type 1 diabetes
have no known family history of the disease. Type 1 diabetes is more common
among whites than among members of other racial groups. In contrast, members
of Native American, African American, and Hispanic ethnic groups are at
higher risk for developing type 2 diabetes. Perhaps the genetic make up
of nonwhites predisposes them to the obesity and diabetes that tend to
result from a 20th century sedentary American lifestyle.
A major
difference in the characteristics of individuals with type 1 and type
2 diabetes is the age of onset. Typically, type 1 diabetes develops in
individuals under the age of 40. Half of all people diagnosed with type
1 diabetes are under the age of 20. In contrast, most of the
people diagnosed
with type 2 diabetes are over the age of 30, although type 2 diabetes
is on the rise in teenagers. The risk for type 2 increases with age. Half
of all new cases of type 2 diabetes ae in people age 55 and older.
Type 2 diabetes
is more common in overweight and obese individuals, whereas body weight
does not seem to be a risk factor for type 1 diabetes. Type 2 diabetes
is often found in women with a history of giving birth to babies weighing
more than 9 pounds an din women who were previously diagnosed with gestational
diabetes. In both men and women, high blood pressure and very high concentrations
of fats in the blood are more common in people with type 2 diabetes.
You can't
get diabetes - either type 1 or type 2 - from stress, exposure to someone
who already has diabetes, or from something you ate. And although diabetes
may reveal itself after an illness or a stressful experience, these may
have only speeded up the appearance of the disease.
CAUSES
OF TYPE 1 DIABETES
In people
with type 1 diabetes, the immune system mistakenly destroys the insulin
- producing beta cells in the pancreas, treating them as if they were
a foreign invander. This is called an autoimmune response. Autoimmune
responses also occur in other disease such as multiple sclerosis, lupus,
and thyroid diseases like hypothyroidism and hyperthyroidism. Researchers
do not know exactly why this happens. But for diabetes, researchers have
found many factors that appear to be linked to type 1 diabetes. These
include genetics, autoantibodies, viruses, cow's milk and oxygen free
radicals.
GENETICS
Scientists
have long suspected that heredity plays a role in diabetes, especially
in type 1 diabetes. This is because type 1 diabetes seems to run in families
- if your mother or father had diabetes for example, you are more likely
to develop the disease that someone without a family history. Also, type
1 diabetes seems to be more common in certain racial groups. Whites, for
example, are more likely to develop the disease than are people from other
racial backgrounds. Type 1 diabetes occurs in less than 1 in 100,000 people
in Shanghai, China, but occurs in greater than 35 in 100,000 people in
Finland.
Everyone
is born with a set of instructions that tells the cells in your body how
to grow live, and function. These instructions lie in the particular chemical
sequence of units known as bases that make up the DNA in every cell in
your body. Each cell in your body contains 46 chromosomes, which are made
up of DNA of protein. Each DNA strand is like a long string that contain
millions of bases. Along the strand lie the genes, unique segments of
DNA that tell you cells what kind of protein to make.
But just
as books sometimes contain typographical errors, so too does the sequence
of DNA. If there is a mistake, or mutation, in the DNA within a gene,
then a faulty protein may be made that can't do its job. Scientists are
trying to determine how to mistakes in specific genes cause diabetes.
If mutated genes occur in germ cells - the eggs and sperm - then the DNA
mutations can be passed on from generation to generation.
Researchers
have identified several different genes that might make a person more
likely to develop type 1 diabetes, However, they have not found one single
gene that makes all people who inherit it develop the disease. Instead,
it sems that there are several genes known as "diabetes susceptibility"
genes.
One particular
set of genes that may predispose a person to diabetes is responsible for
the human leukocyte antigens, or HLAs. These genes code for certain proteins
called antigens, which identify a person's own cells as "self".
They tell the immune cells not to destroy the cells that are part of person's
body. Scientists believe that some HLA antigens incorrectly identify the
beta cells as non-self. Then the immune cells, which normally destroy
froeign invading cells, destroy these cells. This called autoimmunity
- an immune attack on a person's own cells. In type 1 diabetes, the insulin
- producing cells of the pancreas are destroyed in an autoimmune attack,
and the body can no longer make insulin. This destructive process occurs
over many months.
Each person
has many kinds of HLA genes, and thus there are many typesof HLAs. Each
person inherits one of each kind of HLA gene from each parent. One type
of HLA gene, known as HLA-DR, is most strongly linked to type 1 diabetes.
There are many variations of HLA-DR, but 95 percent of people with type
1 diabetes have the DR3 form, the DR4 form, or both. This makes researchers
suspect that having the DR3 and DR4 variants may make a person more likely
to get type 1 diabetes. However, this is not the whole answer, because
45 percent of people without type 1 diabetes have the DR3 or DR4 variants.
Also, variants of another HLA gene, known as HLA-DQ, may also play a role
in type 1 diabetes.
Just because
a person inherits a susceptible HLA variant doesn't mean that person witll
develop diabetes. Most people with DR3 or DR4 variants remain helathy.
But if there is a family hisotry of type 1 diabetes, then screening may
help predict the risk of developing the disease. For example, borthers
and sisters of a person with diabetes who have two of the same HLA-DR
variants have a 15 percent chance of getting type 1 diabetes. But if they
share only one variant, the risk is only 5 percent. If no variants are
the same, the risk of developing type 1 diabetes is 1 percent or less.
The more
we study how people get type 1 diabetes, the more we understand that the
answers are not simple. No one event or characteristic seems to bring
on diabetes. Researchers have identified several other gene clusters on
different chromosomes in addition ot these HLA variants that may also
play a role in type 1 diabetes.
AUTOANTIBODIES
The immune
system protects you from disease by killing germs and other foreign invaders.
It does this largely through the action of white blood cells, or lymphocytes.
T lymphocytes, or T cells, can attack foreign cells directly. B lymphocytes,
or B cells, produce special proteins called antibodies that recognize
this shapes of molecuels on the surface of specific invaders.
B cells
sometimes manufacture antibodies that recognize a person's own cells.
These self recognizing antibodies are called autoantibodies. Autoantibodies
are found in many people with autoimmune disorders, but three autoantibodies
are especially common in people with type 1 diabetes. These antibodies
recognize :
- Islet
cells (beta cells are just one type of islet cell in the pancreas)
- Insulin
- Glutamic
acid decarboxylase, a protein made by the beta cells in the pancreas.
This protein is also called GAD, or the 64K protein.
These three
types of autoantibodies all seem to act as markers. Researchers believe
that these antibodies contribute to the demise of the beta cells of the
pancreas by identifying which cells are to be attached. It is really the
T cells that ultimately destroy the insulin - producing cells of the pancreas.
Of people newly diagnosed with type 1 diabetes, 70 to 80 percent have
antibodies to islet cells, 30 to 50 percent have anitbodies to insulin,
and 80 to 95 percent have antibodies to GAD.
The antibodies
may be present several years before diabetes is dagnosed. The islet cell
antibodies disappear later on. Because these antibodies are so common
in people with type 1 diabetes and because they so often appear before
the symptoms of diabetes appear, researchers are finding that theya re
useful in screening people for type 1 diabetes who are at high risk for
the disease. Although the risk for developing diabetes may only be 1 to
10 percent for people with a parent or sibling with the disease, a much
higher percentage of people who also have antibodies to islet cells develop
type 1 diabetes within 5 years. And for many, having combinations of these
antibodies and certain HLA genes results in an even higher risk.
By testing
relatives of people with type 1 diabetes for autoantibodies, doctors and
researcheres can often predict who is likely to develop the disease. This
could be especially useful as new therapies emerge, because they can be
strated before damage to the pancreas is too extensive. For example, by
identifying people who are likely to develop type 1 diabetes at are early
stage, researchers may be able to treat with insulin or drugs that suppress
the immune system and thus prevent the T cells from destroying the beta
cells in the pancreas.
Some people
with a high risk of getting type 1 diabetes have participated in studies
to see whether immunosuppressants such as azathioprine or cyclosporine
delay or prevent the onset of the disease. Researchers are also testing
to see whether long-acting insulin, oral insulin, or nicotinamide can
delay or prevent diabetes. These studies suggest that axathioprine or
cyclosporine can reduce the dose of insulin needed in people who have
already developed type 1 diabetes, if the drug is started at the time
the disease is diagnosed.
Other therapies
may also be tested as researchers learn more about how autoantibodies
contribute to diabetes. For example, if autoimmunity to GAD turns out
to be a primayr trigger of type 1 diabetes, it might be possible to develop
a vaccine that would protect people from developing the disease.
VIRUSES
Perhaps surprisingly,
many scientists also suspect that viruses may cause type 1 diabetes. This
is because people who develop type 1 diabetes have often recently had
a viral infection, and "epidemics" of type 1 diabetes often
occur after viral epidemics. Viruses, like those that cause mumps and
German measles and Coxsackie family of viruses, which is related to the
virus that causes polio, may play some role in cauisng type 1 diabetes.
A small
region of the GAD molecule is almost identical to a region of a protein
found in the virus known as Coxsackie B4. The two similar protein regions
probably have similar shapes and may be recognized by the same T cells.
Thus, to a T cell hunting for foreign invaders, the GAD protein, which
is part of the body, might look the same as the Coxsackie virus protein,
which is part of an invading cell. After a viral infection by the Coxsackie
virus, the T cell, bent on destroying the invading virus, might actually
destroy the body's own beta cells that bear the GAD protein. This would
destroy the cells that produce insulin and result in type 1 diabetes.
Other theories
may also explain how a viral infection might lead to diabetes. Some researchers
believe that when a virus in fects a body, it might somehow change the
structure of the antigens on the surface of the islet cells. If this occurs,
then the altered antigen might appear to be foreign to the immune system,
and a person's own insulin-producing islet cells might be destroyed.
Gian Franco
Bottazzo, a well-known diabetes researcher, has another theory. He believes
that diabetes is a relatively new disease caused by a slow acting virus.
Although such a virus has not been found, Bottazzo holds that the virus
causes the immune system to attack proteins in the pancreas. A drastic
increase in the number of cases of type 1 diabetes occurred on the island
of Sardinia, Italy, in the 1960s and in Finland in the 1970s, and he believes
that such a slow-acting virus could be the culprit.
COW'S
MILK
It seems
unlikely, but different kinds of food may pay a role in the development
of type 1 diabetes. For example, one group of researchers found a connection
between being fed cow's milk early in life and type 1 diabetes. They showed
that children newly diagnosed with type 1 diabetes have higher amounts
of antibodies that recognize a specific protein in cow's milk. These autoantibodies
appear to bind to a protein that sometimes appears on the surface of the
insulin-producing beta cells int eh pancreas after an illness. The researchers
speculate that, after an illness, the transient protein may appear on
the surface of beta cells. The immune response to the milk protein might
be to then recognize the beta cell surface proteins and attack the beta
cells, leading to a destruction of the insulin - producing cells of the
pancreas, and thus, to type 1 diabetes.
However,
other researchers have looked for but not found an increased risk of type
1 diabetes if cow's milk is given early in life and if breast feeding
is done for a short period. Cow's milk is only one kind of food that may
play a role in the development of type 1 diabetes. Studies in diabetes
- prone rats show that withholding wheat and soy helps delay or prevent
diabetes.
OXYGEN
FREE RADICALS
No, these
are not part of some terrorist organization, but they may as well be.
Oxygen free radicals, formed a s a by product of many chemical reactions
in the body, wreak havoc wherever they go. Normally, the body has ways
of quenching free radicals. But smoke, air pollution, diet, and even genetics
can be contribute to the formation of excessive amounts of free radicals,
which the body cannot always handle. Uncontrolled, the reactive molecules
can destroy the body's own cells as well as bacteria. Oxygen free radicals
contribute significantly to the aging process and to the development of
several other diseases. Researchers have implicated free radicals in the
development of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease,
a degenerative neuromuscular disease.
Some researchers
believe that oxygen free radicals may also contribute to type 1 diabetes.
Islet cells have very low levels of the enzymes that break down free radicals.
Thus, agents that increase free radical production could result in destruction
of pancreatic cells. If this is true, then researchers may be able to
develop drugs that block the formation of free radicals in the islet cells.
CHEMICALS
AND DRUGS
Several chemicals
have been shown to trigger diabetes. Pyriminil, a poison used to kill
rats, can trigger type 1 diabetes. Two prescription drugs, pentamidine,
used to treat pneumonia, and L-asparaginase, an anticancer drug, can also
cause type 1 diabetes. Other chemicals have been shown to make animals
diabetic, but scientists don't know for sure whether they have the same
effect in humans.
It is unlikely
that either genetics or environmental factors alone cause diabetes. But
it does appear that a person could start with a genetic susceptibility
- the inheritance of a particular set of genes. If this person is then
exposed to some environmental "triggering" factor, such as a
virus or a chemical, then diabetes may develop. Although no one is destined
to develop diabetes with certainty, a person's heredity increases the
odds.
CAUSES
OF TYPE 2 DIABETES
The reasons
that type 2 diabetes occur are different from those that trigger type
1 diabetes. Unlike people with type 1 diabetes, who become unable to produce
insulin, people with type 2 diabetes produce insulin. But, either the
body does not respond to insulin's action - it's resistant - or there
is just not enough insulin to go around - there's too much body for the
amount of insulin that's made. Either problem leads to the same outcome:
insulin can't deliver glucose to the cells that need it, and there's too
much glucose in the blood.
Virtually
all cells in the body contain special proteins called receptors that bind
to insulin. They work like a lock and key. In order for glucose to enter
the cell, insulin must first fit into the insulin receptor. But for some
reason, in some people with type 2 diabetes, there is a faulty lock, or
insulin receptor. The key doesn't open the lock, and glucose is shut out
of the cell. And in some people with type 2 diabetes, there are not enough
locks, or insulin receptors, on the cells to allow enough glucose to enter.
But for most people with diabetes it's not so much that the key doesn't
fit the lock, but that insulin doesn't work properly. In rare cases, the
insulin is mutated, or built incorrectly, and does not fit the insulin
receptor.
In addition
to problems with insulin and the insulin receptor, in many people with
type 2 diabetes, the beta cells in the pancreas do not produce enough
insulin. Without enough insulin to meet the body's needs glucose level
rise and diabetes results. Scientists do not know why the pancreas does
not function well in these people. Some believe that the system that controls
glucose levels in the blood and tells the pancreas to make more insulin
does not function properly. Other think that the pancreas, after many
years of working overtime, overproducing insulin to overcome insulin resistance,
simply begins to "burn out."
Although
researchers do not fully understand why type 2 diabetes develops, they
have uncovered many factors that may contribute to the disease.
GENETICS
Genetics
also appear to play a role in how type 2 diabetes develops. Like type
1 diabetes, type 2 diabetes also appears to run in families, and it is
most likely due to the inheritance of certain genes. The link to genetics
seems even stronger in type 2 diabetes than in type 1 diabetes. If a person
with type 1 diabetes had an identical twin, there is a 25 to 50 percent
chance that the twin, will develop diabetes. But if a person with type
2 diabetes has an identical twin, there is 60 to 75 percent chance that
the person will develop diabetes.
More evidence
for the role of genes in type 2 diabetes comes from studying minorities.
Compared with whites, African Americans, Asian Americans, Hispanic Americans,
and Native Americans all get type 2 diabetes more often. Native Americans
have the highest rate of type 2 diabetes in the World. Hispanic groups,
such as Mexican Americans, that share genes with Native American groups
have a higher rate of type 2 diabetes than Hispanic groups, such as Cuban
Americans, where less intercultural contact has occurred.
Researchers
have not yet isolated a single "type 2 diabetes" gene, but they
are finding errors in several that may contribute to type 2 diabetes.
For example, researchers have identified a protein called PC-1 that shuts
down the insulin receptor, which creates insulin resistance. This protein
is prevalent in most people with type 2 diabetes, compared with people
without diabetes. For some reason, too much of the inhibitor protein is
made in some people, and the insulin receptor cannot do its job properly,
which can lead to insulin resistance.
Researchers
believe that the genes that lead to obesity may also play a role in diabetes.
In mice, scientists have identified a gene they called the obese gene.
The obese gene appears to regulated body weight by making proteins that
affect the center in the brain that tells you whether you're full or hungry.
When the obese gene is mutated, the mice become obese and develop type
2 diabetes.
AGE, OBESITY,
AND LIFESTYLE
The most
important environmental trigger of type 2 diabetes appears to be obesity.
Obesity is defined as weighing more than 20 percent over your desirable
body weight. Genetics may play a role in obesity and, thus, in triggering
type 2 diabetes.
In some
way, having too much body fat promotes resistance to insulin. This is
why, for so many years, type 2 diabetes has been treated with diet and
exercise. Losing weight and increasing the amount of muscle while decreasing
the amount of fat helps the body use insulin better. There is also a link
between type 2 diabetes and where your body is too fat. People with central
body obesity, which means carrying excess fat above the lips, have a higher
risk of developing type 2 diabetes than those with excess fat on the hips
and thighs.
Central
body obesity, as well as overall obesity, is more common in African Americans
than in whites. This may be one reason why type 2 diabetes is also more
common in African Americans than in whites.
Age also
appears to play a role. Half of all new cases of type 2 diabetes occur
in people over age 55. Because people tend to gain weight as they age,
many researchers think that the reason more older people develop diabetes
is because more older people are overweight.
Leading
an inactive, sedentary lifestyle and consuming a high-calorie diet can
also lead to type 2 diabetes, presumably by contributing to obesity. Obesity,
as well as type 2 diabetes, are common in Asian Americans and Hispanic
Americans who have "westernized" their eating and activity habits.
CAUSES
OF GESTATIONAL DIABETES
Like the
other types of diabetes, the exact cause of gestational diabetes is unknown.
However, experts do have some clues.
HORMONES
During pregnancy,
the placenta, which is the organ that nourishes the growing baby, produces
large amounts of various hormones. Hormones are important for the baby's
growth. However, these hormones may also block insulin's action in the
mother's body, causing insulin resistance. All pregnant women have some
degree of insulin resistance.
Gestational
diabetes usually appears around the 24th week of pregnancy. This is when
the placenta begins producing large quantities of the hormones that cause
insulin resistance. For this reason, the period between the 24th and 28th
weeks of pregnancy is a good time to screen for gestational diabetes.
GENETICS
Because insulin
resistance, rather than underproduction of insulin, seems to cause gestational
diabetes it is more like type 2 diabetes than type 1 diabetes. And having
gestational diabetes increases your chances of someday developing type
2 diabetes. Researchers suspect that the genes responsible for type 2
diabetes and for gestational diabetes may be similar.
Some women show signs of high blood glucose even before the 28th week
of pregnancy. Doctors believe that these women probably had diabetes that
was unrecognized before the pregnancy began. The weight gain and hormonal
changes of pregnancy stressed the body and revealed the diabetes. This
can happen with either type 1 or type 2 diabetes. Doctors would carefully
watch what happens after the pregnancy in order to diagnose type 1 or
type 2 diabetes.
OBESITY
Gestation
diabetes is more common in groups that have more obesity. For instance,
it is found more often in areas with a large number of Hispanic Americans,
in whom obesity is more common. Obesity can trigger gestational diabetes
as well as type 2 diabetes.
Traveler's
Diarrhea
BACK
Whenever
a person travels from one country to another - particularly if the change
involves a marked difference in climate, social conditions, or sanitation
standards and facilities - diarrhea is likely to develop within 2 - 10
days. There may be up to ten or even more loose stools per day, often
accompanied by abdominal cramps, nausea, occasionally vomiting, and rarely
fever. The stools do not usually contain mucus or blood, and aside from
weakness dehydration there are no systemic manifestations of infection.
The illness usually subsides spontaneously within 1 - 5 days. Although
10% remain symptomatic for a week or longer, an din 2% symptoms persist
for longer than a month.
Bacteria
cause 80% of cases of traveler's diarrhea, with enterotoxigenic E coli,
shigella species, and campylobacter jejuni being the most common pathogens.
Less common causative agents include aeromonas, salmonella, noncholera
vibrious. Entamoeba histolytica, and Giardia lamblia. Contributory causes
may at times include unusual food and drink, change in living habits,
occasional viral infections, and change in bowel flora. In patients with
fever and bloody diarrhea, stool culture may be indicated, but in most
cases cultures are reserved for those who do not respond to antibiotics.
Chronic watery diarrhea may be due to amebiasis or giardiasis or, rarely,
tropical sprue.
For most
individuals, the affliction is short-lived, and symptomatic therapy with
opioids or loperamide is all that is required provided the patient is
not systemically ill and does not have dysentery, in which case antimotility
agents should be avoided. Packages of oral rehydration salts to treat
dehydration are available over the counter in the USA and in many foreign
countries. Avoidance of fresh foods and water sources that are likely
to be contaminated is recommended for travelers to developing countries,
where infectious diarrheal illnesses are endemic. Prophylaxis is remended
for those with significant underlying disease and for those whose full
activity status during the trip is so essential that even short periods
of diarrhea would be unacceptable. Prophylaxis is started upon entry into
the destination country and is continued for 1 or 2 days after leaving.
For stays of more than 3 weeks, prophylaxis is not recommended because
of the cost and increased toxicity. For prophylaxis, bismuth subsalicylate
is effective but turns the tongue and the stools black and can interfere
with doxycyline absorption, which may be needed for malaria prophylaxis.
Numerous antimicrobial regimens for once-daily prophylaxis also are effective,
such as n orfloxacin 400 mg, ciprofloxacin 500 mg, lfloxacin 300 mg, or
trimethoprim - sulfamethoxazole 160/80 mg. Because not all travelers will
have diarrhea and because most episodes are brief and self-limited, an
alternative approach that is currently recommended is to provide the traveler
with a supply of antimicrobials to be taken if significant diarrhea occurs
during the trip. Loperamide with a single dose of ciprofloxacin, or olfloxacin
cures most cases of traveler's diarrhea. If diarrhea is severe, associated
with fever or bloody stools, or persists despite single-dose ciprofloxacin
treatment, then 3 - 5 days of ciprofloxacin 500 mg twice daily, levofloxacin
500 mg once daily, norfloxacin 400 mg twice daily, or ofloxacin 300 mg
twice daily can be given. Trimethoprim-sulfamethoxazole 160/800 mg twice
daily can be used as an alternative, but resistance is common in many
areas.
BACK
Disorders
due to Heat
BACK
Four medical
disorders comprise a spectrum of illness that can result from excessive
exposure to hot environments: heat syncope, hear cramps, heat exhaustion,
and heat stroke. A stable internal temperature requires a balance between
heat production and heat loss, which the hypothalamus regulates in initiating
changes in muscle tone, vascular tone, and sweat gland function.
Etiology
Sweat production
and evaporation is a major mechanism of heat removal. Conduction - the
direct transfer of heat from the skin to the surrounding air - also occurs,
but with diminished efficiency as the ambient temperature rises. The passive
transfer of heat from a warmer to a cooler object by radiation accounts
for 65% of body heat loss decreases as the temperature of the surrounding
environment increases up to 37.2, the point at which heat transfer reverses
direction. At normal temperatures, evaporation accounts for approximately
20% of the body's heat loss, but at high temperature is becomes the major
mechanism for dissipation of heat; with vigorous exertion, sweat loss
can be as much as 2.5 L/h. This mechanism is also limited as humidity
increases.
Health conditions
that inhibit sweat production or evaporation and increase susceptibility
to heat disorders include obesity, generalized skin diseases, diminished
cutaneous blood flow, dehydration, malnutrition, hypotension, and reduced
cardiac output. Medications that impair the sweating mechanism are the
anticholinergics, antihistamines, phenothiazines, tricyclic antidepressants,
monoamine oxidase inhibitors, and diuretics; reduced cutaneous blood flow
results from use of vasoconstrictors and - adrenergic blocking agents;
and dehydration results from use of alcohol. Illicit drugs eg, phencyclidine,
LSD, amphetamines, and cocaine - can cause increased muscle activity and
thus generate increased body heat. Drug withdrawal syndromes may have
the same effect, as may prolonged seizures.
The risk
of heat disorder also increased with age, impaired cognition, concurrent
illness, reduced physical fitness, and insufficient acclimatization.
Prevention
Medical evaluation
and monitoring should be used to identify individuals at increased risk
of heat disorders. The exposed public should be made aware of the early
symptoms and signs of heat disorders. It is not recommended to make salt
tablets available for use without medical supervision; close monitoring
of fluid and electrolyte intake may be necessary in situations necessitating
activity in hot environments. Athletic events should be organized and
managed with attention to thermoregulation: the WBGT Index should be encouraged,
and medical support should be immediately accessible. Competition is not
recommended when the WBGT exceeds 28 C. Workers should not begin work
in hot temperatures without proper acclimatization and should be encouraged
to drink water or balanced electrolyte fluids frequently.
Protective
cooled suits have been used successfully in industry for prolonged work
in environment up to 60 C.
Acclimatization
is achieved by scheduled regulated exposure to hot environments and by
gradually increasing the duration of exposure and the work load until
the body adjusts by starting to produce sweat of lower salt content in
greater amounts at later ambient temperatures. Acclimatization is accompained
by increased plasma volume, cardiac output, and cardiac stroke volume
and a slower heart rate.
SPECIFIC
SYNDROMES DUE TO HEAT EXPOSURE
1. Heat
Syncope
Sudden unconsciousness
can result from cutaneous vasodilation with consequent systemic and cerebral
hypotension. Systolic blood pressure is usually less than 100 mm Hg, and
there is typically a history of vigorous physical activity for 2 hours
or more just preceding the episode. The skin is typically cool and moist
and the pulse is weak.
Treatment
consist of rest and recumbency in a cool place, with fluids by mouth
2. Heat
Cramps
Fluid and
electrolyte depletion can result in slow, painful skeletal muscle contractions
and even severe muscle spasms lasting 1 - 3 minutes, usually of the muscles
most heavily used. Cramping results from salt depletion as sweat losses
are replaced with water alone. The skin is moist and cool, and the muscles
are tender. There may be muscle twitching. The victim is alert, with stable
vital signs, but may be agitated and complaining of pain. The body temperature
may be normal or slightly increased. Involved muscle groups are hard and
lumpy. There is almost always a history of vigorous activity just preceding
the onset of symptoms. Laboratory evaluation may show low serum sodium,
hemoconcentration, and elevated urea and creatinine.
The patient
should be moved to a cool environment and given oral saline solution to
replace both salt and water. Because of their slower absorption, salt
tablets are not recommended. The victim may have to rest for 1 - 3 days
with continued dietary salt supplementation before returning to work or
resuming strenuous activity in the heat.
3. Heat
Exhaustion
Heat exhaustion
results from prolonged heavy activity with inadequate salt intake in a
hot environment and is characterized by dehydration, sodium depletion,
or isotonic fluid loss with accompanying cardiovascular changes.
The diagnosis
is based on prolonged symptoms and a rectal temperature over 37.8 C, increased
pulse rare - usually more than half again the patient's normal rate -
and moist skin. Symptoms associated with heat syncope and heat cramps
may also be present. The patient may be quite thirsty and weak, with central
nervous system symptoms such as headache, fatigue, and, in cases due chiefly
to water depletion, anxiety, paresthesias, impaired judgment, hysteria,
and occasionally psychosis. Hyperventilation secondary to heat exhaustion
can lead to respiratory alkalosis. Heat exhaustion may progress to heat
stroke if sweating ceases.
Treatment
consist of patient location in a shaded, cool environment, providing adequate
hydration, salt replenishment - orally, if possible - and active cooling
if necessary. Physiologic saline or isotonic glucose solution can be administered
intravenously in severe cases or when oral administration is not appropriate.
Intravenous 3% saline may be necessary if sodium depletion is severe.
At least 24 hours of rest is recommended.
4. Heat
Stroke
Heat stroke
is a life - threatening medical emergency resulting from failure of the
thermoregulatory mechanism. Heat stroke is imminent when the core temperature
approaches 41 C. It presents in one of two forms: Classic heat stroke
occurs in patients with compromised hoemostatic mechanism: exertional
heat stroke occurs in previously healthy persons undergoing strenuous
exertion in a thermally stressful environment. Morbidity or even death
can result from cerebral , cardiovascular, hepatic, or renal damage.
The hallmarks
of heat stroke are cerebral dysfunction with impaired consciousness, high
fever, and absence of sweating. Persons at greatest risk are the very
young, the elderly or chronically infirm, and patients receiving medications
that interfere with heat-dissipating mechanisms.
Exertional heat stroke and exertion - related illnesses, including rhabdomyolysis,
are appearing more frequently as including rhabdomyolysis, are appearing
more frequently as complications of participation by unconditioned amateurs
in strenuous athletic activities such as marathon running and triathlon
competition.
Clinical
Findings
A. Symptoms
and Signs
Failure of the heat dissipation mechanism for any reason result in dizziness,
weakness, emotional liability, nausea and vomiting, diarrhea, confusion,
delirium, blurred vision, convulsions, collapse, and unconsciousness.
The skin is hot and initially covered with perspiration. Later it dries.
The pulse is strong initially. Blood pressure may be slightly elevated
at first, but hypotension develops later. The core temperature is usually
over 41 C. As with heat exhaustion, hyperventilation can occur, leading
to respiratory alkalosis.
Exertional
heat stroke may present with sudden collapse and loss of consciousness
followed by irrational behavior. Anhidrosis may not be present. Twenty-five
percent of heat stroke victims have prodromal symptoms for minutes to
hours that may include dizziness, weakness, nausea, confusion, disorientation,
drowsiness, and irrational behavior.
B. Laboratory
Findings :
Laboratory evaluation may reveal dehydration leukocytosis, elevated BUN,
hyperuricemia, hemoconcentration, acid-base abnormalities, and decreased
serum potassium, sodium, calcium, and phosphorus; urine is concentrated,
with elevated protein, tubular casts, and myoglobinuria. Thrombocytopenia,
increased bleeding and clotting times, fibrinolysis, and consumption coagulopathy
may also be present. Rhabdomyolysis and myocardial, hepatic, or renal
damage may be identified by elevated serum creatine kinase and aminotransferase
levels and BUN and by the presence of anuria, proteinuria, and hematuria.
Electrocardiographic findings may include ST - T changes consistent with
myocardial ischemia.
Treatment
Treatment is aimed at reducing the core temperature rapidly and controlling
the secondary effects. Evaporative cooling is rapid and effective and
is easily performed in most emergency settings. The patient's clothing
should be removed and the entire body sprayed with water while cooled
or ambient air is passed across the patient's body with large fans or
other means at high velocity. The patient should be in the lateral recumbent
position or supported in a hands - and - knees position to expose as much
skin surface as possible to the air. Other alternatives include use of
cold wet sheets accompained by fanning or immersion in chilled water.
Cardiopulmonary bypass provides rapid cooling but is often not practical.
Immersion
is an ice-water bath as initial treatment is no longer preferred because
of its greater potential for complications of hypotension and shivering.
However, it should be considered if core temperature is not decreased
rapidly in response to other treatment. Alternatives include hand forearm
immersion in cold water, ice packs, and iced gastric lavage, though these
are much less effective than evaporative cooling.
Treatment
should be continued until the rectal temperature drops to 30 C. The temperature
remains stable in most cases, but it should continue to be monitored for
24 hours. Chlorpromazine or diazepam can be give initially and then every
4 hours to control shivering and other muscular activity associated with
increased heat load. Antipyretics have no effect on environmentally induced
hyperthermia and are contraindicated.
Hypovolemic
and cardiogenic shock must be carefully distinguished, as either or both
may occur. Central venous or pulmonary artery wedge pressure should be
monitored. Five percent destrose in half-normal or normal saline should
be administered for fluid replacement.
The patient
should also be observed for renal failure due to rhabdomyolysis, hypokalemia,
cardiac arrhythmias, disseminated intravascular coagulation, and hepatic
failure. Hypokalemia frequently accompanies heat stroke but may not appear
until rehydration. Maintenance of extracellular hydration and electrolyte
balance should reduce the risk of renal failure due to rahbdomyolysis.
Fluid administration to ensure a high urine output, mannitol administration
, and alkalinizing the urine are recommended. Corticosteroids have not
been shown to be of value.
Fluid output
should be monitored through the use of an indwelling urinary catheter.
Because
sensitivity to high environmental temperature continues in some patients
for prolonged periods following an episodes of heat stroke, immediate
reexposure should be avoided.
BACK
DROWNING
BACK
Drowning
is the fifth leading cause of accidental death in the USA. The number
of deaths due to drowning could undoubtedly be significantly reduced if
adequate preventive and first aid instruction programs were instituted.
The asphyxia
of drowning is usually due to aspiration of fluid, but it may result from
airway obstruction caused by laryngeal spasm while the victim is gasping
under water. About 10% of victims develop laryngospasm after the first
gulp and never aspirate water. The rapid sequence of events after submersion
- hypoxemia, laryngospasm, fluid aspiration, ineffective circulation,
brain injury, and brain death - may take place within 5 - 10 minutes.
This sequence may be delayed for longer periods if the victim, especially
a child, has been submerged in very cold water or if the victim has ingested
significant amounts of barbiturates. Immersion in cold water can also
cause a rapid full in the victim's core temperature, so that systemic
hypothermia and death may occur before actual drowning.
The primary
effect is hypoxia due to perfusion of poorly ventilated alveoli, intrapulmonary
shunting, and decreased compliance. The first requirement of rescue is
immediate cardiopulmonary resuscitation.
A number
of circumstances or primary events may precede near drowning and must
be taken into consideration in management: (1) use of alcohol or other
drugs, (2) extreme fatigue, (3) intentional hyperventilation, (4) sudden
acute illness, (5) head or spinal cord injury sustained in diving, (6)
venomous stings by aquatic animals, and (7) decompression sickness in
deep water diving.
When first
seen, the near-drowning victim may present with a wide range of clinical
manifestations. Spontaneous return of consciousness often occurs in otherwise
healthy individuals when submersion is very brief. Many other patients
respond promptly to immediate ventilation. Other patients, with more severe
degrees of near drowning, may have frank respiratory failure, pulmonary
edema, shock, anoxic encephalopathy, cerebral edema, and cardiac arrest.
A few patients may be deceptively asymptomatic during the recovery period
- only to deteriorate or die as a result of acute respiratory failure
within the following 12 - 24 hours.
Clinical
Findings
A. Symptoms
and Signs
The patient
may be unconscious, semiconscious, or awake but apprehensive, restless,
and complaining of headaches or chest pain. Vomiting is common, Examination
may reseal cynaosis, trismus, apnea, tachypnea, and wheezing. A pink froth
from the mouth and nose indicates pulmonary edema. Cardiovascular manifestations
may include tachycardia, arrhythmias, hypotension, cardiac arrest, and
circulatory shock. Hypothermia may be present.
B. Laboratory
Findings :
Urinalysis
shows proteinuria, hemoglobinuria, and acetonuria. Leukocytosis is usually
present. The Pao2 is usually decreased and the Paco2 is increased or decreased.
The blood pH is decreased as a result of metabolic acidosis. Chest X-rays
may show pneumonitis or pulmonary edema.
Prevention
Prevention consists of avoidance of alcohol during recreational swimming
or boating, close supervision of toddlers, swimming lessons early in life,
and use of personal flotation devices when boating. All swimming pools
should be fenced.
Treatment
A. First
Aid :
Immediate
measures to combar hypoxemia at the scene of the incident - with sustained
effective ventilation, oxygenation, and circulatory support - are critical
to survival with complete recovery. Hypothermia and cervical spine injury
should always be suspected.
1. Standard
CPPR is initiated if pulse and respiration are absent.
2. Do not waste time attempting to drain water from the victim's lungs,
since this measure is most often in no value. The Heimlich maneuver should
be used only if airway obstruction by a foreign body is suspected. The
cervical spine should be immobilized if neck injury is possible.
3. Do not discontinue basic life support for seemingly "hopeless"
patients until core temperature reaches 32 C. Complete recovery has been
reported after prolonged resuscitation of hypothermic patients.
B. Hospital
Care :
Careful observation
of the patient; continuous monitoring of cardiorespiratory function; serial
determination of arterial blood gases, pH, renal function, and electrolytes;
and measurement of urinary output are required. Pulmonary edema may not
appear for 24 hours.
1. Ensure
optimal ventilation and oxygenation
The danger of hypoxemia exists even in the alert, conscious patient who
appears to be breathing normally. Oxygen should be administered immediately
at the highest available concentration. Endotracheal intubation and mechanical
ventilation are necessary for patients unable to maintain an open airway
or normal blood gases and pH. Nasogastric intubation will allow removal
of swallowed water and prevention of aspiration. If the victim does not
have spontaneous respirations, intubation is required. Oxygen saturation
should be maintained at 90% or higher. Continuous positive airway pressure
is the most effective means of reversing hypoxia in patients with spontaneous
respirations and patients airways. Positive end expiratory pressure is
also effective for treating respiratory insufficiency. Assisted ventilation
may be necessary with pulmonary edema, respiratory failure, aspiration,
pneumonia, or severe central nervous system injury. Serial physical examinations
and chest X-rays should be carried out to detect possible pneumonitis,
atelectasis, and pulmonary edema. Bronchospasm due to aspirated material
may require use of bronchodilators. Antibiotics should be given only when
there is clinical evidence of infection - not prophylactically.
2. Cardiovascular
support - Central venous pressure may be monitored as a guide to determining
whether vascular fluid replacement and pressors or diuretics are needed.
If low cardiac output persists after adequate intravascular volume is
achieved, pressors should be given. Otherwise, standard therapy for pulmonary
edema, cardiogenic or not, is administered.
3. Correction
of blood pH and electrolyte abnormalities - Metabolic acidosis is present
in 70% of near-drowning victims, but it is usually of monitor importance
and corrected through adequate ventilation and oxygenation. While controversial,
bicarbonate administration has been recommended for comatose patients.
4. Cerebral
injury - Some near-drowning patients may progress to irreversible central
nervous system damage despite apparently adequate treatment of hypoxia
and shock. Mild hyperventilation to achieve a PaCo2 of approximately 30
mm Hg is recommended to lower intracranial pressure.
5. Hypothermia
- Core temperature should be measured and managed as appropriate.
Course
& Prognosis
Victims of near drowning who have had prolonged hypoxemia should remain
under close hospital observation for 2 - 3 days after all supportive measures
have been withdrawn and clinical and laboratory findings have been stable.
Residual complications of near drowning may include intellectual impairments,
convulsive disorders, and pulmonary or cardiac disease.
BACK
ELECTRIC
SHOCK
BACK
The possibility
of life-threatening electrical injury exists wherever there is electric
power or lightning. The amount and type of current, the duration and area
of exposure, and the pathway of the current through the body determine
the degree of damage. If the current passes through the heart or brain
stem, death may occur immediately owing to ventricular fibrillation or
apnea. Current passing through skeletal muscle can cause muscle necrosis
and contractions severe enough to result in bone fracture. Current traversing
peripheral nerves can cause acute or delayed neuropathy. Delayed effects
can include damage to the spinal cord, peripheral nerves, bone, kidneys,
and gastrointestinal tract as well as cataracts.
Direct current
is less dangerous than alternating current. With alternating currents
of 25 - 300 Hz, low voltages tend to produce ventricular fibrillation;
high voltages, respiratory failure; intermediate voltages, both. More
than 100 mA of domestic house current of 110 volts at 60 Hz is, accordingly,
dangerous to the heart, since it can cause ventricular fibrillation. DC
current contact is more likely to cause asystole.
Lightning
injuries differ from high-voltage electric shock injuries in that lightning
usually involves higher voltage, briefer duration of contact, asystole
rather than ventricular fibrillation, nervous system injury, and multisystem
pathologic involvement.
Electrical
burns are of three distinct types: flash burns, flame burns, and the direct
heating effect of tissues by the electric current. The latter lesions
are usually sharply demarcated, round or oval, painless yellow-brown areas
with inflammatory reaction. Significant subcutaneous damage can be accompanied
by little skin injury, particularly with larger skin surface area electrical
contact.
Electric
shock may produce loss of consciousness. With recovery there may be muscular
pain, fatigue, headache, and nervous irritability. The physical signs
vary according to the action of the current. Ventricular fibrillation
or respiratory failure can occur; the patient may be unconscious, pulseless,
hypotensive, cold and cyanotic, and without respirations.
Electric
shock may be a hazard in equipment that is usually considered to be harmless.
Proper installation, utilization, and maintenance of equipment by qualified
personnel should minimize this hazard.
Treatment
A. Emergency
Measures :
The victim
must be freed from the electric current prior to initiation of CPR or
other treatment; the rescuer must be protected. Turn off the power, sever
the wire with a dry wooden - handled axe, make a proper ground to divert
the current, or drag the victim carefully away by means of dry clothing
or a leather belt.
Lightning
injury. Victims of lightning injury, in whom coma may last for a few minutes
to several days, should receive prompt and sustained artificial resuscitation.
This should be continued as long as there is no clinical evidence of brain
death.
B. Hospital
Measures :
Lightning
or unstable electric shock victims should hospitalized when revived and
observed for shock, arrhythmia, thrombosis, infarction, sudden cardiac
dilation, hemorrhage, and myoglobinuria. A urinalysis, serum Ck and CK-MB,
and an electrocardiogram should be obtained immediately. Victims should
also be evaluated for blunt trauma, dehydration, skin burns, hypertension,
posttraumatic stress, acid-base disturbances, and neurologic damage. Indications
for hospitalization include significant arrhythmia or electrocardiographic
changes, large burn, loss of consciousness, pulmonary or cardiac symptoms,
or evidence of significant deep tissue or organ damage. Extra caution
is indicated when the electroshock current has followed a transthoracic
route (hand to hand or hand to foot) and in patients with a cardiac history.
To counteract fluid losses and myoglobinuria due to electric shock (not
lighting ) burns, aggressive hydration with Ringer's lactate should seek
to achieve a urine output of 50-100 mL/h.
Prognosis
Complication
may occur in almost any part of the body but most commonly include sepsis,
gangrene requiring limb amputation, or neurologic, cardiac, cognitive,
or psychiatric dysfunction.
TREATMENT
OF COMMON SPECIFIC POISONINGS
(ALPHABETICAL ORDER)
BACK
ACETAMINOPHEN
Acetaminophen
is a common analgesic found in many nonprescription and prescription products.
After absorption, it is metrabolized mainly by glucuronidation and sulfation,
with a small fraction metabolized via the P450 mixed-function oxidase
system to a highly toxic reactive intermediate. This toxic intermediate
is normally detoxified by cellular glutahione. With acute acetaminophen
overdose, hepatocellular glutathione is rapidly depleted and the reactive
intermediate attacks other cell proteins, causing necrosis. Patients with
enhanced P450 activity, such as chronic alcoholics and patients taking
anticonvulsants, are at increased risk of developing hepatotoxicity. Hepatic
toxicity may also occur after chronic accidental overuse of acetaminophen
- eg, as little as 1 g of acetaminophen every 4 - 6 hours for 1 - 2 days
in a patient with chronic accidental overuse of acetaminophen - eg, as
little as 1g of acetaminophen every 4 - 6 hours for 1 - 2 days in a patient
with chronic excessive alcohol use.
Clinical
Findings
Shortly after
ingestion, patients may have nausea or vomiting, but there are usually
no other signs of toxicity until 24 - 48 hours after ingestion, when hepatic
aminotransferase levels begin to increase. With severe poisoning, massive
hepatic necrosis may occur, resulting in jaundice, hepatic encephalopathy,
renal failure, and death.
The diagnosis
of severe poisoning after acute over-dose is based on measurement of the
serum acetaminophen level. Plot the serum level versus the time since
ingestion on the acetaminophen nomogram. Ingestion of sustained-release
produces or coingestion of an anticholinergic agent, salicylate, or opioid
drug may cause delayed elevation of serum levels.
Treatment
A. Emergency
and Supportive Measures :
Empty the
stomach by emesis or gastric lavage. Administer activated Charcoal. Although
charcoal may bind the oral antidote aceylecysteine, this is not considered
clinically significant.
B. Specific
Treatment
If the serum
acetaminophen level is higher than the upper toxic line on the nomogram,
begin treatment with a loading dose of acetylcysteine, 140 mg/kg orally,
followed by 70 mg/kg every 4 hours. Dilute the solution to 5% with water,
juice, or soda. If vomiting interferes with oral acetylcysteine administration,
give the dose by gastric tube and use metoclopramide, 1 - 2 mg/kg intravenously.
The most widely used protocol in the USA continues treatment for 72 hours.
However, other regimens have demonstrated equivalent success with 20 -
48 hours of treatment. Treatment with acetylcysteine is most effective
if started within 8 --10 hours after ingestion. If the precise time of
ingestion is unknown or if the patient is at higher risk of hepatotoxicity,
then use a lower threshold for initiation of acetylcysteine.
Acetylcysteine
may also be given intravenously; this is the preferred method in Europe
and Canada, but there is no approved parenteral formulation or dosing
schedule in the United States. If the patient cannot tolerate acetylcysteine
despite antiemetics and administration via a gastric tube, the United
States formulation may be give intravenously. Call a regional poison control
centre or medical toxicologist for assistance.
ACIDS,
CORROSIVE
The strong
mineral acids exert primarily a local corrosive effect on the skin and
mucous membranes. Symptoms include severe pain in the throat and upper
gastrointestinal tract; bloody vomitus; difficulty in swallowing, breathing,
and speaking; discoloration and destruction of skin and mucous membranes
in and around the mouth; and shock. Severe systemic metabolic acidosis
may occur both as a result of cellular injury and from systemic absorption
of the acid.
Severe deep
destructive tissue damage may occur after exposure to hydrofluoric acid
because of the penetrating and highly toxic fluoride ion. Systemic hypocalcemia
and hyperkalemia also may occur after fluoride absorption, even following
skin exposure.
Inhalation
of volatile acids, fumes, or gases such as chlorine, fluorine, bromine,
or iodine causes severe irritation of the throat and larynx and may cause
upper airway obstruction and noncardiogenic pulmonary edema.
Treatment
A. Ingestion
Do not induce
emesis. Dilute immediately by giving a glass of milk or water to drink.
Do not give bicarbonate or other neutralizing agents. Some experts recommend
immediate gastric lavage.
Perform
flexible endoscopic esophagoscopy promptly to determine the presence and
extent of injury. X-rays of the chest and abdomen may reveal the presence
of free air in patients with esophageal or gastric perforation. Perforation,
peritonitis, and major bleeding are indications for surgery.
B. Skin
Contact :
Flood with
water for 15 minutes. Use no chemical antidotes; the heat of the reduction
may cause additional injury.
For hydrofluoric
acid burns, soak the affected area in magnesium sulfate solution or apply
2.5% calcium gluconate gel; then arrange immediate consultation with a
plastic surgeon or other specialist. Binding of the fluoride ion may be
achieved by injecting 0.5 mL of 5% calcium gluconate per square centimeter
under the burned area. (Caution : Do not use calcium chloride).
C. Eye
Contact
Anesthetize
the onjunctiva and corneal surfaces with topical local anesthetic drops.
Flood with water for 15 minutes, holding the eyelids open. Check pH with
pH 6.0 - 8.0 test paper, and repeat irrigation, using 0.9% saline, pH
is near 7.0. Check for corneal damage with fluorescein and slitlamp examination;
consult an ophthalmologist about further treatment.
D. Inhalation
Remove from
further exposure to fumes or gas. Check skin and clothing. Treat pulmonary
edema.
ALKALIES
The strong
alkalies are common ingredients of some household cleaning compounds and
may be suspected by their "soapy" texture. Those with alkalinity
above pH 12.0 are particularly corrosive. Clinitest tables and disk batteries
are also a source. Alkalies cause liquefactive necrosis, which is deeply
penetrating. Symptoms include burning pain in the upper gastrointestinal
tract, nausea, vomiting, and difficulty in swallowing and breathing. Examination
reveals destruction and edema of the affected skin and mucous membranes
and bloody vomitus and stools. X-ray may reveal the presence of disk batteries
in the esophagus or lower gastrointestinal tract.
Treatment
A. Ingestion
Do not induce
emesis. Dilute immediately with a glass of water. Some gastroenterologists
recommend immediate gastric lavage after ingestion of liquid caustic substances
to remove residual material.
Immediate
endoscopy is recommended to evaluate the extent of damage. If X-ray reveals
the location of ingested disk batteries in the esophagus, immediate endoscopic
removal is mandatroy.
The use
of corticosteroids to prevent stricture formation is of no proved benefit
and is definitely contraindicated if there is evidence of esophageal perforation.
B. Skin
Contact :
Wash with
running water until the skin no longer feels soapy. Relieve pain and treat
shock.
C. Eye
Contact :
Anesthetize
the conjunctival and corneal surfaces with topical anesthetic. Irrigate
with water or saline continuously for 20 - 30 minutes, holding the lids
open. Check pH with pH test paper, and repeat irrigation, using 0.9% saline,
for additional 30 minute periods until the pH is near 7.0. Check for corneal
damage with fluorescein and slitlamp examination; consult an ophthalmologist
for further treatment.
AMPHETAMINES
& COCAINE
Amphetamines
and cocaine are widely abused for their euphorigenic and stimulant properties.
Both drugs may be smoked, snorted, ingested, or injected. Amphetamines
and cocaine produce central nervous system stimulation and a generalized
increase in central and peripheral sympathetic activity. The toxic does
of each drug is highly variable and depends on the route of administration
and individual tolerance. The onset of effects is most rapid after intravenous
injection or smoking. Amphetazine derivatives and related drugs include
methamphetamine, and methcarthinone. Nonprescription medications and nutritional
supplements may contain stimulant or sympathomimetic drugs such as ephedrine
or caffeine. Phenylpropanolamine was recently withdrawn from the market
because of an increased incidence of hypertensive intracerebral hemorrhage
in young women.
Clinical
Findings
Patients
may present with anxiety, tremulousness, tachycardia, hypertension, diaphoresis,
dilated pupils, agitation, muscular hyperactivity , and psychosis. Metabolic
acidosis may occur. In severe intoxication, seizures and hyperthermia
may occur. Sustained or severe hypertension may result in intracranial
hemorrhage, aortic dissection, or myocardial infarction. Hyponatremia
has been reported after MDMA use; the mechanism is not known but may involve
excessive water intake, SIADH, or both.
The diagnosis
is supported by finding amphetamines, cocaine, or the cocainemetabolite
benzoylecgonine in the urine. Blood screening is not sensitive enough
to detect these drugs.
Treatment
A. Emergency
and Supportive Measures
Maintain
a patent airway and assist ventilation, if necessary. Treat coma or seizures.
Rapidly lower the body temperature in patients who are hyperthermic. Treat
agitation or psychosis with a benzodiazeine such as diazepam, 5 - 10 mg
intravenously, o rmidazolam, 0.1 - 0.2 mg/kg intramuscularly.
For poisoning
by ingestion, perform gastric lavage and administer activated charcoal,
or administer activated charcoal alone without prior gut emptying. Do
not induce emesis, because of the risk of seizures.
B. Specific
Treatment
Treat agitation
with a sedative as lorazepam, 2 - 3 mg intravenously. Treat hypertension
with a vasodilator drug such as phentolamine or nifedipine or a combined
- and - adrenergic blocker such as labetalol. Do not administer a pure
beta - blocker such as propranolol alone, as this may result in paradoxic
worsening of the hypertension as a result of unopposed - adrenergic effects.
Treat tachycardia or tachyarrhythmias with a short-acting beta-blocker
such as esmolol.
ANTICOAGULANTS
Warfarin
and related compounds inhibit the clotting mechanism by blocking hepatic
synthesis of vitamin K-dependent clotting factors.
Anticoagulants
may cause hemoptysis, gross hematuria, bloody stools, hemorrhages into
organs. Wide spread bruising, and bleeding into joint spaces. The prothrombin
time is increased within 12 - 24 hours after a single overdose. After
ingestion of brodifacoum and indanedione rodenticides, inhibition of clotting
factor synthesis may persist for several weeks or even months after a
single dose.
Treatment
A. Emergency
and Supportive Measures:
Discontinue
the drug at the first sign of gross bleeding, and determine the prothrombin
time. If the patient has ingested an acute overdose, empty the stomach
by emesis or lavage and administer activated charcoal.
B. Specific
Treatment
Do not treat
prophylactically - wait for the evidence of anticoagulation. If the prothrombin
time is elevated, give phytonadione, 5 - 10 mg subcutaneously or 10 -
25 mg orally, and additional doses as needed to restore the prothrombin
time to normal. Give fresh-frozen plasma as needed to rapidly correct
the coagulation factor deficit if there is serious bleeding. If the patient
is chronically anticoagulated and has strong medical indications for being
maintained in that status, give much smaller doses if vitamin k and flesh
- frozen plasma as titrate to the desired prothrombin time.
If the patient
has ingested brodifacoum or a related superwarfarin, prolonged observation
and repeated administration of large doses of vitamin k may be required.
ANTICONVULSANTS
(Carbamazepine, Phenytoin, Valporic Acid)
There drugs
are widely used in the management of seizure disorders. In addition, carbamazepine
and valproxic acid are increasingly used for treatment of mood disorders.
Phenytoin
can be given orally or intravenously. Rapid intravenous injections of
phenytoin can cause acute myocardial depression and cardiac arrest owing
to the solvent propylene glycol; a never form of phenytoin is available
that does not contain this diluent. Phenytoin intoxication can occur with
only slightly increased doses because of the small toxic- therapeutic
window. Phenytoin intoxication can also occur following acute intentional
of accidental overdose. The overdose syndrome is usually mild even with
high serum levels. The most common manifestations are ataxia, nystagmus,
and drowsiness. Choreoathetoid movements have been described.
Carbamazepine
was first used for the treatment of trigeminal neuralgia. It has since
become a first-line agent for temporal lobe epilepsy and other seizure
disorders. Intoxication causes drowsiness, stupor, and, with high levels,
coma and seizures. Dilated pupils and tachycardia are common. Toxicity
may be seen with serum levels greater than 20 mg/L, though severe poisoning
is usually associated with concentrations greater than 30 - 40 mg/L. Because
of erratic and slow absorption, intoxication may progress over several
hours to days.
Valporic
acid intoxication produces a unique syndrome consisting of hypernatremia,
metabolic acidosis, hypocalcemia, elevated serum ammonia, and mild liver
aminotransferase elevation. Hypoglycemia may occur as a result of hepatic
metabolic dysfunction, Coma with small pupils may be seen and can mimic
opioid poisoning. Encephalopathy and cerebral edema can occur.
Treatment
A. Emergency
and Supportive Measures :
For recent
ingestion, give activated charcoal orally or by gastric tube. For large
ingestions of carbamazepine or valporic acid - especially of sustained-release
for mulations - consider whole bowel irrigation. Multiple-dose activated
charcoal may be beneficial in ensuring gut decontamination for large ingestions
and may enhance elimination of absorbed drugs.
B. Specific
Treatment
There are
no antidotes. Naloxone was reported to have reversed valptoic acid overdose
in one anecdotal case. Consider hemodialysis or hemoperfusion for massive
intoxication.
ARSENIC
Arsenic is
found in pesticides and industrial chemicals. Symptoms of poisoning usually
appear within 1 hour after ingestion but may be delayed as long as 12
hours. They include abdominal pain, vomiting, watery diarrhea, and skeletal
muscle cramps. Profound dehydration and shock may occur. In chronic poisoning,
symptoms can be vague but often include those of peripheral sensory neuropathy.
Urinary arsenic levels may be misleading and are falsely elevated after
certain meals that contain large quantities of relatively nontoxic organic
arsenic.
Treatment
A. Emergency
Meausres
Induce vomiting
or perform gastric lavage, and administer 60 - 100 g of activated charcoal.
B. Antibote
:
For symptomatic
patients or those with massive overdose, give dimercaprol injection, 10%
solution in oil, 3 - 5 mg/kg dimercaprol intramuscularly every 4 - 6 hours
for 2 days. The side effects include nausea, vomiting, headache, and hypertension.
Follow dimercaprol with oral penicillamine, 100 mg/kg/d in four divided
doses, 10 mg/kg every 8 hours, for 1 week. Consult a medical toxicologist
or regional poison control centre for advice regarding chelation.
ATROPINE
& ANTICHOLINERGICS
Atropine,
scopolamine, belladonna, diphenoxylate with atropine. Datura stramonium,
Hyoscyamus niger, some mushrooms, tricyclic antidepressants, and antihistamines
are antimuscarinic agents with variable central nervous system effects.
The patient complains of dryness of the mouth, thirst, difficulty in swallowing,
and blurring of vision. The physical signs include dilated pupils, flushed
skin, tachycardia, fever, delirium, myocolonus, ileus, and flushed appearance.
Antidepressants and antihistamines may induce convulsions.
Antihistamines
are commonly available with or without prescription. Diphenhydramine commonly
causes delirium, tachycardia, and seizures. Massive overdose may mimic
tricyclic antidepressant poisoning. The nonsedating agents terfenadine
and astemizole have caused QT interval prolongation and torsade de pointes.
Loratidine has not caused this problem.
Treatment
A. Emergency
and Supportive Measures
Perform gastric
lavage, and administer activated charcoal. Do not induce emesis in patients
who have ingested antihistamines or antidepressants, because seizures
may occur abruptly. Tepid sponge baths and sedation are indicated to control
high temperatures.
B. Specific
Treatment
For pure
atropine or related anticholinergic syndrome, if symptoms are severe,
give p hysostigmine salicylate, o.5 - 1 mg slowly intravenously over 5
minutes, with electrocardiographic monitoring, until symptoms are controlled.
Bradyarrhythmias and convulsions are a hazard with physostigmine administration,
and it should not be used in patients with tricyclic antidepressed overdose.
BETA-ADRENERGIC
BLOCKERS
There are
wide variety of beta-adrenergic blocking drugs, with varying pharmacologic
and pharmacokinetic properties. The most commonly used and most toxic
beta-blocker is propranolol. Propranolol competitively blocks beta1 and
beta2 adrenoceptors and also has direct membrane depressant and central
nervous system effects.
Clinical
Findings
The most
common findings with mild or moderate intoxication are hypotension and
bradycardia. Cardiac depression from more severe poisoning is often unresponsive
no conventional therapy with beta-adrenergic stimulants such as dopamine
and norepinephrine. In addition, with propranolol and other lipid - soluble
drugs, seizures and coma may occur.
The diagnosis
is based on typical clinical findings. Routine toxicology screening does
not usually include beta-blockers.
Treatment
A. Emergency
and Supportive Measures :
Initially,
treat bradycardia or heart b lock with atropine, isoproterrenol by intravenous
infusion, titrated to the desited, or an external transcutaneous cardiac
pacemaker. Specific antidotal treatment may be necessary.
For ingested
drugs, empty the stomach by gastric lavage and administer activated charcoal.
Do not induce emesis because of the risk of seizures.
B. Specific
Treatment :
If the above
measures are not successful in reversing bradycardia and hypotension,
give glucagon, 5 - 10 mg intravenously, followed by an infusion of 1 -
5 mg/h. Glucagon in an inotropic agent that acts as a different receptor
site and is therefore not affected by beta-blockade.
CALCIUM
CHANNEL BLOCKERS
Calcium channel
blockers used in the United States include verapamil, diltiazem, nifedipine,
nicardipine, amlodipine, felodipine, isradipine, nisoldipine, and nimodipine.
These drugs share the ability to cause arteriolar vasodilation and depression
of cardiac contractility, especially after acute overdose. Patients may
present with bradycardia. AV nodal block, hypotension, or a combination
of these effects. With severe poisoning, cardiac arrest may occur.
Treatment
A. Emergency
and Supportive Measures
Maintain
a patient airway and assist ventilation, if necessary. Treat coma, hypotension,
and seizures as described at the beginning of this chapter. Treat bradycardia
with atropine, isoproterenol, or a transcutaneous or internal cardiac
pacemaker.
For ingested
drugs, perform gastric lavage and administer activated charcoal. In addition,
whole bowel irrigation should be initiated as soon as possible if the
patient has ingested a sustained - release product. Because of the risk
of hypotension and seizures, do not induce emesis.
B. Specific
Treatment :
If bradycardia
and hypotension are not reversed with these measures, administer calcium
chloride intravenously. Start with calcium chloride 10%, 10 mL, or calcium
gluconate, 20 mL. Repeat the dose every 3 - 5 minutes. The optimum dose
has not been established, but there are reports of success after as much
as 10 - 12 g of calcium chloride. Calcium is most useful in reversing
negative inotropic effects and is less effective for AV nodal blockade
and bradycardia. Epinephrine infusion and glucagon, 5 - 10 mg intravenously,
have also been recommended.
CARBON
MONOXIDE
Carbon monoxide
is a colorless, odorless gas produced by the combustion of carbon-containing
materials. Poisoning may occur as a result of suicidal or accidental exposure
to automobile exhaust, smoke inhalation in a fire, or accidental exposure
to an improperly vented gas heater or other appliance. Carbon monoxide
avidly binds to hemoglobin, with an affinity approximately 250 times that
of oxygen. This results in reduced oxygen-carrying capacity and altered
delivery of oxygen to cells.
Clinical
Findings
At low carbon monoxide levels, victims may have headache, dizziness, abdominal
pain, and nausea. With higher levels, confusion, dyspnea, and syncope
may occur. Hypotension, coma, and seizures are common with levels greater
than 50 - 60%. Survivors of acute severe poisoning may develop permanent
neurologic deficits. The fetus and newborn may be more susceptible because
of high carbon monoxide affinity for fetal hemoglobin.
Carbon monoxide
poisoning should be suspected in any person with severe headache or acutely
altered mental status, especially in cold weather, when improper heating
systems may have been used. Diagnosis depends on specific measurement
of the arterial or venous carboxyhemoglobin saturation, although the level
may have declined if high-flow oxygen therapy, has already been administered.
Routine arterial blood gas testing and pulse oximetry are not useful because
they may give fulsely normal oxyhemoglobin saturation determination.
Treatment
A. Emergency
and Supportive Measures :
Maintain
a patent airway and assist ventilation, if necessary. Remove the victim
from exposure. Treat patients with coma. Hypotension, or seizures, as
described at the beginning of this chapter.
B. Specific
Treatment :
The half-life
of the carboxyhemoglobin complex is about 4 - 5 hours in room air but
is reduced dramatically by high concentration of oxygen. Administer 100%
oxygen by tight-fitting high flow reservoir face mask or endotracheal
tube. Hyperbaric oxygen can provide 100% oxygen under higher than atmosphere
pressures, further shortening the half-life; it may be useful if immediately
available for patients with coma or seizures and in pregnant women, though
controlled studies have failed to prove that HBO is superior to high -
flow oxygen at normal pressure.
BACK
Candidiasis
(Oral Thrush; Vaginal Yeast infection; Esophageal Candidiasis)
BACK
What is
it?
Thrush, also
called candidiasis, is a disease caused by a fungus. Everyone has this
fungus both on and inside their bodies. It can be found on the skin, in
the stomach, the colon and rectum, the vagina, and in the mouth and throat.
Most of the time. Candidia albicans is harmless and actually helps keeps
bacteria levels in check. Sometimes. However, there is an overgrowth of
this fungus, which can lead to a variety of problems.
Both HIV-positive
and HIV-negative people can develop candidiasis. Many women experience
vaginal yeast infections, a type of candidiasis. Similarly, a person can
experience an overgrowth of fungus in their mouth or the back of their
throat. Stress, poor diet, or not getting enough rest can contribute to
these problems. Also, a person who takes antibiotics for bacterial infections,
especially for long periods of time, can develop thrush in their mouth
or vagina. Candidiasis in the mouth can also occur in people who use inhaled
steroids, such as those used to treat asthma and other lung problems.
Poor oral
hygiene and smoking can also play a role in fungal overgrowth in the mouth.
Excessive alcohol and sugar consumption have also been linked to the development
of candidiasis.
In HIV-positive
people, oral thrush and vaginal yeast infections can occur at any time,
regardless of their T-cell counts. The more the immune system becomes
damaged, oral thrush and vaginal yeast infections are more likely to occur
and recur more frequently. HIV-positive people with damaged immune systems,
usually with a T-cell count less than 200, are also more likely to develop
candidiasis deeper in their bodies, such as in their esophagus or their
lungs.
What are
the symptoms of candidiasis?
Symptoms
of candidiasis depend on the part of the body affected. If you have any
of the symptoms, you should contact your doctor:
The symptoms
of candidiasis
- Oral candidiasis
: Some of the general symptoms of oral thrush include burning pain in
the mouth or throat, altered taste, and difficulty swallowing. Oral
candidiasis appears as white or pinkish-red blotches on the tongue,
gums, the sides or roof of the mouth, and the back of the throat. Sometimes,
oral candidiasis can cause the corners of the mouth to become chapped,
cracked, and sore.
- Vaginal
candidiasis: The most obvious symptom of vaginal yeast infections is
a thick white discharge resembling cottage cheese. It can also cause
itching and burning in or around the vagina, as well as a rash and tenderness
of the outer lips of the vagina. HIV-positive women are more likely
to experience recurrent vaginal yeast infections than HIV-negative women.
- Esophageal
candidiasis: This is a type of candidiasis that occurs deep down in
the throat and can't always be seen by looking into the mouth. It can
cause chest pain, as well as pain and difficulty when swallowing. Esophageal
candidiasis is much common in HIV-positive people with suppressed immune
systems.
How is
candidiasis diagnosed?
Most of the
time, a doctor can diagnose candidiasis simply by looking in the mouth,
at the back of the throat, or in the vagina. Sometimes it is necessary
to scrape the overgrowth so that a sample can be sent to a lab. X-rays
and a special scope - called an endoscope - are used to look for candidiasis
down the throat.
How is
candidiasis treated?
Just as there
are three different types of candidiasis, there are three somewhat different
ways to treat the disease.
Oral Candidiasis
The most
common method of treating oral thrush is to use a medicated liquid that
is swished around the mouth and swallowed, or a lozenge that is sucked,
dissolved in the mouth, and swallowed. The three most common treatments
are:
- Clotrimazole:
These trouches, or lozenges, are used either four or five times a day
for one or two weeks. Lozenges should be dissolved in the mouth slowly
and should not be chewed or swallowed whole. Clotrimazole can cause
stomach upset.
- Nystain
: Nystatin is available in liquid and pastille form. The liquid dose
is 5 milliliters four times a day for one or two weeks; it should be
swished around the mouth slowly, for as long as possible, and then swallowed.
One or two pastilles are taken four or five times a day for 7 to 14
days; they should be dissolved in the mouth slowly and should not be
chewed or swallowed whole.
- Amphotericin
B: Amphotericin B is available in a liquid for the treatment of oral
candidiasis. The usual dose is 100 mg a day, four times a day. A medicine
dropper is used to place the liquid directly onto the tongue. The liquid
should be swished around the mouth slowly, for as long as possible,
and then swallowed.
If oral candidiasis
does not go away with the use of these drugs or recurs soon after treatment
is stopped, more potent drugs such as ketoconazole, itraconazole, or fluconazole
can be taken. Unlike swish-and-swallow liquids and lozenges, these drugs
are swallowed immediately and are more likely to cause side effects, including
stomach upset, diarrhea, nausea, and elevated liver enzymes.
Another possible
treatment for oral cnadidiasis is gentian violet. This is a dye made from
coal tar and can be purchased from some pharmacies, health food stores,
and other places where complementary / alternative therapies are sold.
Gentian violet is very messy and can stain clothing. It should be handled
with care. For oral thrush, one of the best ways to apply the dye is by
using a cotton swab. Dip the swab in the dye and coat the Candida blotches
in the mouth. It is best to avoid swallowing the drug, as it can cause
stomach upset. Gentian violet can also stain the inside of the mouth,
but this fades over time.
Vaginal
Candidiasis
The most common method of treating vaginal yeast infections is to use
a medicated cream or an insert placed into the vagina. The most common
treatments for vaginal candidiasis are available over-the-counter and
can be purchased in many pharmacies. Many vaginal creams and suppositories
can weakencondoms and diaphragms, which can increase the risk of pregnancy
and HIV transmission.
- Clotrimazole
(Gyne-Lotrimin cream): Five grams of this cream and applied everyday,
using a special applicator, for 7 to 14 days.
- Clotrimazole
(Mycele vaginal suppositories): Available in 100 mg and 500 mg strength
suppositories and are available by prescription. The 100 mg suppositories
are used every day for seven days. Alternatively, two 100 mg suppositories
can be used every day for total three days. The 500 mg suppository is
much more powerful than that 100 mg inserts and only needs to be inserted
once.
- Miconazole
(Monistal vaginal cream) : five grams of this cream are applied every
day, using a special applicator, for seven days.
- Miconazole
(Monistat vaginal suppositories) : Available in 100 mg, 200 mg, and
500 mg strengths. The 100 mg and 200 mg suppositories are available
over-the-counter and the 500 mg suppositories are available by prescription.
The 100 mg suppositories are used once a day for seven days and the
200 mg suppositories are used once a day for three days. The 500 mg
suppository only needs to be inserted once.
- Terconazole
(Terazol 3 and Terazol 7 creams) : Terazol 3 contains a higher dose
of terconazole than Terazol 7. Terazol 7 is applied every day, using
a special applicator, for seven days. Terazol 3 is applied every day
for three days.
- Terconazole
(Terazol 3 suppositories ) : These suppositories contain 80 mg terconazole
and are inserted every day for three days.
- Tioconazole
(Vagistat ointment) : The ointment contains 300 mg tioconazole and is
inserted, using a special applicator, only once.
- Butoconazole
(Fernstat cream) : Five grams of this cream are applied every day, using
a special applicator, for three days.
As with oral
candidiasis, if vaginal yeast infections do not go away while using these
creams of suppositories, or if the infection returns soon after treatment
is stopped, more potent drugs such as ketoconazole, of fluconazole can
be prescribed by a doctor. Women who are pregnant should not use these
oral drugs. They may harm the developing fetus.
Another possible
treatment for vaginal yeast infections is gentian violet. This is a dye
made from coal tar and can be purchased from some pharmacies, health food
stores, and other places where complementary/alternative therapies are
sold. Genapax can be purchased in a tampon formulation; each tampon contains
5 mg of gentian violet. Gentian violet tampons can be messy and can stain
clothing and undergarments. They should be handled and inserted with care.
To treat vaginal yeast infections, gentian violet tampons are inserted
once or twice a day for one to two weeks.
Esophageal
Candidiasis
Because esophageal candidiasis is considered to be more severe, deeper
in the body, and harder to treat than either oral thrush or vaginal yeast
infections, more powerful drugs - using higher doses than those used to
treat oral of vaginal candidiasis - are usually needed to treat it. These
drugs can cause liver enzymes to increase. They can also interact with
other medications, including protease inhibitors, non-nucleoside reverse
transcriptase inhibitors, as well as certain antihistamines and sedatives.
Be sure to check with your doctors about other drugs you are taking before
taking these antifungal treatments.
- Itraconazole
: This drug is frequently used to treat esophageal candidiasis.
Many doctors are now recommending that the liquid formula be used. If
the itraconazole tablets are used, they are often taken with another
drug, flucytosine, to increase effectiveness. For oral candidiasis,
the dose of itraconazole used is usually 100 mg a day for one or two
weeks. For esophageal candidiasis, the dose is usually 200 mg a day
for two or three weeks. Itraconazole tablets should be taken with food;
itracanazole liquid should be taken on an empty stomach.
- Fluconazole:
To treat esophageal candidiasis, a 200 mg tablet of fluconazole is taken
once a day or two or three weeks.
- Ketoconazole:
400 mg of Nizoral is taken every day for three or four weeks. This drug
interacts with many antiretroviral drugs. It can increases indinavir,
saquinavir, and amprenavir levels in the blood. Ritonavir can increase
the amount of ketoconazole in the blood and, as a result, the daily
ketoconazole dose should not exceed 200 m.
Severe
or Drug-Resistant Candidiasis
Sometimes, candidiasis can become resistant to the "azole" drugs
or is so severe that it cannot be adequately treated using any of these
treatments. As a result, a drug called amphotericin B is often used. It
is usually administered in a hospital through an IV line. The two types
of amphotericin B are standard amphotericin B and liposomal amphotericin
B.
Amphotericin
B can cause serious side effects, include kidney damage, allergic reactions,
bone marrow damage, nausea vomiting, and headache. The risk of kidney
damage is increased if amphotericin B is combined with cidofovir or ganciclovir,
two drugs used to treat CMV, and pentamidine, a drug used to treat PCP.
The risk of bone marrow damage is increased if amphotericin B is taken
at the same time as AZT, flucytosine, or ganciclovir.
Generally
speaking, the liposomal amphotericin B brands are less toxic than standard
amphotericin B. However, standard amphotericin B is faster acting than
any of the liposomal drugs and is usually the drug of choice when candidiasis
or other fungal infections and severe and an immediate threat to life.
Can candidiasis
be prevented?
There is
no guaranteed way to prevent oral thrush, vaginal yeast infections, or
the more serious forms of candidiasis from occurring. These infections
are more likely to occur in HIV-positive people with compromised immune
systems. Thus, one way to help prevent candidiasis from occurring is the
keep the immune system healthy, such as by using antiretroviral drugs,
reducing stress, eating right, and getting plenty of rest.
There is
still some debate regarding the use of antifungal drugs to prevent candidiasis.
There have been a few studies showing that fluconazole can reduce the
number of oral or vaginal fungal infections experienced by HIV-positive
people with compromised immune systems. However, it may be possible that
prolonged use of fluconazole - or any of the "azole" drugs -
may lead to the development of drug-resistant. Candida albicans. The can
prevent the drugs from working correctly when they are most needed. Because
of this, many doctors do not recommended that these drugs be used continuously
to prevent candidiasis. However, the prolonged to continual use of antifungal
may be the best option for people with a history of frequent outbreaks
of oral thrush or vaginal yeast infections.
There
are a number of health tips all HIV- positive people should consider to
help prevent candidiasis :
Healthy
topics to prevent Candidiasis
- Watch
your diet: it may be helpful to avoid foods high in sugar, dairy,
yeast, wheat and caffeine. These types of ingredients are believed to
promote fungal overgrowth.
- Eat
yogurt : Many experts also recommend eating lots of yogurt that
contains lactobacillus acidophilus, a "good" bacteria believed
to keep Candidia albicans in check. Not all yogurt brands contain the
bacteria, so be sure the packaging says "contains Lactobacillus
acidophilus."
- Practice
good oral hygiene: This includes brushing regularly, flossing, using
an antiseptic mouthwash, and reducing/eliminating the use of tobacco
products such as chewing tobacco and cigarettes.
- For
vaginal yeast infections: To help reduce the risk of vaginal infections,
wear loose, natural-fiber clothing and undergarments with a cotton crotch.
Also, stay away from deodorant tampons and feminine deodorant sprays.
Are there
any experimental treatments in development for candidiasis?
Candidiasis
is a problem for many people, regardless of whether or not they are infected
with HIV. This is especially true for people who have strains of Candida
that are resistant to currently available drugs. Thus, new drugs are always
being developed for candidiasis and other fungal infections.
BACK
Progressive
Multifocal Leukoencephalopathy (PML)
BACK
What is it?
Progressive
multifocal leukocencephalopathy (PML) is a life-threatening infection
of the brain that can occur in people living with HIV. It is caused by
a virus - the JC virus. The "JC" are the initials of the first
patient to be diagnosed with PML. The virus is a polyomavirus, a family
of viruses that also includes human papillomavirus (HPV).
The "progressive"
in PML means that it continues to get worse and often leads to serious
brain damage. The "multifocal" means that the JC virus causes
disease in several different parts of the brain. The "leukoencephalopathy"
means that the disease affects the white matter of the brain. More specifically,
the JC virus infects cells in the brain called oligodentrocytes. These
cells are responsible for producing myelin, a fatty substance that helps
protect nerves in the brain. If too much myelin is lost and not replaced
by oligodentrocytes, the nerves become damaged and eventually stop working
correctly.
More than
70% of all adults in the United States are infected with the JC virus,
usually during early childhood. However, the virus only becomes active
in people who have compromised immune systems. The includes people undergoing
immune-suppressive chemotherapy for cancer and people with damaged immune
systems due to HIV. Prior to the use of combination anti-HIV drug therapy.
It was estimated that between 3% and 10% of all people with AIDS developed
PML. It usually occurs in people with vary low T-cell counts, but has
been seen in some HIV-positive people with as many as 500 T-cells.
PML is almost
always progressive and fatal. Death usually occurs between one and four
months after the first symptoms appear. However, there have been a number
of reported cases with survival ranging from several months to years.
What's more, up to 10% of people with PML spontaneously recover, either
with or without treatment.
What are
the symptoms of PML?
Symptoms
of PML include mental deterioration, vision loss, speech disturbances,
ataxia, paralysis, and coma. In rare cases, seizures may occur.
How is
PML diagnosed?
Many of the
symptoms of PML are similar to those seen with other HIV-related diseases.
Thus, it is important to determine the exact cause of these symptoms so
that the correct treatment can be started.
The most
accurate way to diagnose PML is by conducting a brain biopsy. To do this,
a surgeon will need to remove a small piece of brain tissue and send it
to a lab for analysis. However, a brain biopsy can be risky, especially
for those with compromised immune systems. It is also possible to diagnose
PML by analyzing magnetic resonance imaging scans of the brain and/or
by looking for the JC virus in the fluid surrounding the spinal column.
This requires a spinal tap - a needle inserted into the lower back to
drain spinal fluid so that it can be analyzed.
How is
PML treated?
Unfortunately,
there are no treatments that have been proven to be effective for PML.
A handful of drug treatments have been studied in clinical trials, including:
- Cytarabine,
also known as cytosine arabinoside for Ara-C, is approved for the treatment
of certain cancers. Early studies of this drug suggested that it was
a possible treatment for PML. However, a larger study conducted by the
U.S. government did not find cytarabine to be particularly effective,
whether the drug was injected into a vein or directly into the brain.
- Even though
clinical trial results do not support its use, cytarabine is still prescribed
for some patients with PML. To receive cytarabine, a patient will need
to have a shunt surgically implanted into his or her skull. This allows
doctors to inject cytarabine, through the tube, directly into the brain.
When treatment is started, cytarabine is administered every day for
three days. After that, it is given twice a week for two weeks, followed
by once-weekly intrathecal injections for life.
- Topotecan
is also used to treat certain cancers. Like cytarabine, early studies
suggested that it was effective as a treatment for PML, but a larger
study reported in early 2001 did not find it to be effective.
- Cidofovir
is approved for the treatment of cytomegalovirus. Early test tube studies
found that it was effective against viruses similar to the JC virus.
Two small studies involving humans suggested that it might be useful
in treating PML. Larger studies are still needed to determine how effective
cidofovir really is. Cidofovir can damage the kidneys, thus it should
be combined with probenecid to help protect kidney function.
- High -
dose , delivered through an intravenous line, was one of the first treatments
studied for PML. While it did help slow progression in some patients,
few patients experienced a reversal of symptoms or were able to prevent
death.
The treatment
of PML is not without hope, however. Combination anti-HIV drug therapy
has been shown to be extremely beneficial for HIV-positive patients with
PML. Because PML is most likely to occur in patients with suppressed immune
systems - and anti-HIV therapy has been shown to significantly increased
T-cell counts and the general health of the immune system - HIV-positive
patients with PML are more likely to live longer and to see their symptoms
improve, sometimes dramatically.
Many researchers
agree that HIV-positive patients with PML should use anti-HIV drugs that
are known to cross the "blood-brain barrier" - a protective
coat that lines blood vessels in the brain to prevent toxins from passing
through. Many of the nucleoside analogues, especially, and the non-nucleoside
analogues, particularly, easily pass through the blood-brain barrier,
and are often used to treat patients with other HIV-related brain diseases
. If AZT is used to help treat PML, researches suggest that a daily dose
of 1,000 to 1,200 mg be used.
Can PML
be prevented?
No, not at
the present time. But because immune suppression plays a major role in
the development of PML, the best possible way to prevent this diseases
is to keep the immune system healthy. This includes starting anti-HIV
therapy before the immune system becomes impaired.
BACK
Risks
To Your Liver (hepatotoxicity)
BACK
Introduction
The liver
is one of the largest and most important organs in the human body. It
is located behind the lower right section of your ribs and carries out
numerous functions that your body requires to remain healthy. These are
just a few of the liver's many functions:
- Storing
important nutrients from the food that you eat
- Building
necessary chemicals that your body needs to stay healthy
- Breaking
down harmful substances, like alcohol and other toxic chemicals
- Removing
waste products from your blood
For HIV-positive
people, the liver is of major importance, as it is responsible for making
new proteins needed by the immune system, helps the body to resist infection,
and processes many of the drugs used to treat HIV and AIDS-related infections.
Unfortunately, these same medications can also damage the liver, which
can prevent the liver from performing all of its necessary tasks and can
eventually cause damage to the liver.
"Hepatotoxicity"
is the official term for liver damage caused by medications and other
chemicals. This lesson has been prepared by the staff to help readers
better understand hepatotoxcity, including the ways in which medications
can cause liver damage, the factors that can increase the risk of hepatotoxcity,
and some of the ways in which you can monitor and protect the health of
your liver. If you have questions or concerns about hepatotoxicity, particularly
as it relates to the anti-HIV drugs you are taking, do not be afraid to
discuss them with your doctor.
How do
anti-HIV drugs causes hepatotoxicity?
Even though
anti-HIV drugs are intended to do your health good, the liver recognizes
these medications as toxic compounds. After all, they are not naturally
produced by the body and do contain some chemicals that could potentially
cause damage to your body. Working with the kidneys and other organs,
the liver processes these drugs to render them safer. In the process,
the liver can become "overworked," which can lead to liver damage.
There
are actually two ways that anti-HIV meds can lead to liver damage:
Direct
damage to liver cells:
Liver cells, called hepatocytes, play a vital role in the functioning
of the liver. If these cells begin working too hard to remove chemicals
from the blood, or if they are harmed by other infections, abnormal chemical
reactions can occur that can damage these cells. There are actually three
ways in which this can happen:
- Taking
a very high dose of a drug. If you were to swallow a high dose of an
anti-HIV drug or another medication, this can cause immediate and sometimes
severe damage to liver cells. Almost any drug, if an overdose is taken,
can cause this type of liver damage.
- Taking
standard doses of medication for a long period of time. If you take
medications on a regular basis for a long period of time, there is also
a risk of damage to these liver cells. This usually occurs after several
months or years of taking certain medications. Protease inhibitors have
the ability to cause damage to liver cells if they are used for long
periods of time.
- An allergic
reaction. When we hear the term "allergic reaction," we often
think of itchy skin or runny eyes. However, allergic reactions can also
take place in the liver. If you are allergic to a particular drug, your
immune system can cause your liver to become inflamed as a result or
interactions between very liver proteins and the drug. If the drug is
not stopped, the inflammation can worsen and can cause serious damage
to the liver. Two anti-HIV drugs known to cause such allergic reactions
in HIV-positive people are Ziagen and Viramune. Allergic reactions such
as these usually occur within a few weeks or months after the drug is
started and either may or may not be accompanied by other allergy-repeated
symptoms.
How do
I find out if my anti-HIV drugs are causing liver damage?
The best
indicator o fhepatotoxicity is an increase in certain liver enzymes that
circulate in the bloodstream. The most important enzymes are AST (aspartate
aminotransferase), ALT (alanine aminotransferase), alkaline phosphotase,
and bilirubin. These four enzymes are normally checked as a part of a
"chem screen," a panel of tests that your doctor probably orders
every time you have blood drawn to check your T-cells and viral load.
If you or
your doctor has any reason to suspect that a drug you are taking has been
causing liver injury, then a blood test should be performed, it is always
best to detect hepatotoxicity in its early stages so that steps can be
taken to prevent it from getting worse and to allow the liver to heat.
Most of the
time, hepatotoxicity takes several months or years to develop and usually
begins with mild increases in either AST or ALT that progresses to more
serious increases. Generally speaking, if your AST or ALT levels are elevated
but are no higher than five times the normal range, you have mild to moderate
hepatotoxicity. If your AST is higher than 215 IU/L or your ALT is above
300 IU/L, you have severe hepatotoxicity, which can learn to permanent
liver damage and serious problems.
Fortunately,
as stated above, the vast majority of doctors order chem screens on a
regular basis and are usually able to catch mild-to-moderate hepatotoxicity
before it progresses to severe hepatotoxicity. However, some drugs, such
as Ziagen and Viramune, can result in an allergic reaction in the liver
that can cause liver enzymes to increase sharply soon after the medication
is started. In turn, it is very important that your doctor check your
liver enzymes every two weeks for the first three months if your begin
taking either of these medications.
Increased
liver enzymes can rarely be felt. In other words, you may not have any
physical symptoms, even if your liver enzymes are elevated. Thus, it is
very important that you and your doctor monitor your liver enzymes on
a regular basis using blood tests. However, symptoms can occur in people
with severe hepatotoxicity and these symptoms are very similar to those
associated with viral hepatitis. Symptoms of hepatitis include :
- Anorexia
- Malaise
- Nausea
- Vomiting
- Light-colored
stools
- Unusual
tiredness/weakness
- Stomach
or abdominal pain
- Jaundice
- Loss of
taste for cigarettes
If you are
experiencing any of these symptoms, it is very important that you speak
with your doctor or another health-care provider.
Does hepatotoxicity
occur in everyone taking anti-HIV drugs?
No, it does
not. There have been a number of studies looking at the percentage of
patients who develop hepatotoxicity, according to the different anti-HIV
medications they are taking. One particular study, conducted by researches
at the National Institute of Health, looked at rates a hepatotoxicity
among 10,611 HIV-positive people participating in 21 government-funded
clinical trials conducted between 1991 and 2000. Overall, 6.2% of the
clinical trial participants experienced severe hepatotoxicity. Among the
participants who took a non -nucleoside reverse transcriptase inhibitor
in combination with two nucleoside analogues, severe hepatotoxicity occurred
in 8.2%. Among the participants who took a protease inhibitor in combination
with two nucleoside analogues, severe hepatotoxicity occurred in 5%.
Unfortunately,
clinical trials do not always reflect what is going to happen in the real
world. Many clinical trials only follow participants for a year - and
we know that HIV positive people will need to take these medications for
many years, which can increase the risk of hepatotoxicity. What's more,
most clinical trials enroll patients who don't have other conditions that
can further increase the risk of hepatotoxicity. For example, it is believed
that women and people over the age of 50 are at a higher risk of developing
hepatotoxicity. Obesity and heavy alcohol use can also increase the chances
of hepatotoxicity occurring. There is also a very real concern that HIV-positive
people who are coinfected with hepatitis B or hepatitis C are more likely
to experience hepatotoxicity than those who are city infected with HIV.
I have
HIV and hepatitis C. Does this mean that I can't use anti-HIV medications?
No. Just
because you have chronic hepatitis C or hepatitis B - two viral infections
that can cause the liver to become inflamed and damaged - does not mean
that you cannot take anti-HIV medications. However, it is important to
understand that there may be a higher risk of liver damage occurring if
you have either of these infections and are taking and HIV medications.
While there
have been a number of studies looking at rates of hepatotoxicity among
people coinfected with both HIV and hepatitis C or hepatitis B who are
taking anti-HIV medications, the results often conflict with one another.
For example, one study conducted by the San Francisco Community Health
Network demonstrated that Viramune was the only anti-HIV medication to
significantly increase the risk of hepatotoxicity in people connected
with HIV and either hep C or hep B. But have also been study results suggesting
that Viramune is no more or less likely to cause hepatotoxicity in coinfected
patients than other anti-HIV medications, although it's still important
to watch out for liver enzyme increases during the first three months
of Viramune treatment.
As for the
protease inhibitors, there have been a few studies demonstrating that
Norvir is the most likely to cause hepatotoxicity in HIV positive people
coinfected with hep C or hep B. However, Norvir is rarely used at the
approved dose - much lower doses of Novir are usually used, as it is now
most frequently prescribe to boost other protease inhibitor levels in
the bloodstream. This, in turn, likely decreases the risk of hepatotoxicity
in people who are only infected with HIV or coinfected with HIV and either
hep C or hep B.
If one thing is clear, it is that people who are coinfected with HIV and
either hep C or hep B should work closely with their doctors to come up
with safe and effective treatment plans. For example, many experts now
believe that, if you have HIV and hep C. you should consider starting
hep C treatment while your T-cell counts are high, before treatment is
needed for HIV. Successfully treating or controlling HCV is perhaps, the
best way to reduce the risk of hepatotoxicity once anti-HIV medications
are started.
It is also
important to monitor your liver carefully while taking anti-HIV medications.
You'll want to find out the levels of your liver enzymes before you begin
taking anti-HIV medications. Even if they are higher than normal because
of either hep C or hep B, you can then monitor your levels closely while
on treatment.
Are there
any ways to effectively reverse or prevent hepatotoxicity?
If you have
been told you that your anti-HIV medications are causing liver toxicity,
you and your doctor will likely want to figure out which drug - or which
combination of drugs - are causing your liver enzymes to increase. Working
together, you and your doctor can then determine if it's necessary to
stop the offending drugs, with a possible switch to new medications that
ar eless likely to cause liver toxicity.
Fortunately,
taking proper care of your liver is not limited to avoiding or switching
certain anti-HIV medications. The next few sections of this lesson review
some of the most important things that you can do protect your liver while
you are taking anti-HIV medications.
What's
the deal with alcohol?
There's no
shortage of information concluding that heavy alcohol use - generally
defined as more than five drinks a day - can cause liver damage. It's
also known that heavy alcohol use can worsen liver diseases in people
with hep C and hep B. Although it's still not known if light or moderate
drinking - no more than one to two drinks a day - is harmful to the liver,
especially in people taking medications on a regular basis. If you drink
alcohol, it is very important that you discuss this with your doctor.
It's also important to note that the American Liver Association recommends
no more than one drink a day. Some medicators, such as Flagy, should not
be combined with alcohol, and most experts advise staying away from alcohol
completely if you have hepatitis.
What about
my diet? Can I eat better to improve the health of my liver?
Yes, absolutely.
The liver is not only responsible for processing medications-it must also
process and detoxify the liquids and foods we drink and eat on a daily
basis. In fact, between 85%and 90% of the blood that leaves the stomach
and intestines contains nutrients from the liquids and foods we consume
for further processing by the liver. As a result, a well-balanced diet
is a terrific way to help take some of the stress off the liver and to
help it remain healthy. Here are some tips to consider:
- Eat plentiful
amounts of fruits and vegetables, especially dark green leafy vegetables
and orange and red colored fruits and vegetables.
- Cut down
on fats that may put a lot of stress on the liver, such as dairy products,
processed vegetables oils, deep fried foods that are not fresh and contain
and contain rancid fats, preserved meats and fatty meats.
- Concentrate
on eating "good fats" which contain essential fatty acids.
These are found in cold pressed vegetable and seed oils, avocados, fish,
flaxseed, raw nuts and seeds and legumes. Not only are good fats believed
to be easier for the liver to process, they can help build healthy cell
membranes around the liver cells.
- Do your
best to avoid artificial chemicals and toxins such as insecticides,
pesticides, artificial sweeteners, and preservatives. You should also
be careful regarding the coffee you drink. Many nutritionists recommend
no more than two cups a day and should be brewed from ground natural
coffee, not instant coffee powders.
- Consume
a diverse range of proteins from grains, raw nuts, seeds, legumes, eggs,
seafood, and if desired, free range chicken and lean fresh red meats.
If you are a vegetarian, you may want to consider supplements such as
vitamin B 12, taurine, and carnitine to avoid poor metabolism and fatigue.
- Drink
large amounts of fluids, especially water. Drinking at least eight glasses
of water a day is a must, especially if you're taking anti-HIV medications.
- Be wary
of raw fish or shellfish. Sushi can harbor bacteria that may harm the
liver and shellfish can contain the hepatitis A virus, which can cause
serious liver problems in people who have not received the hepatitis
A vaccine. Also take care to avoid wild mushrooms. Many types of wid
mushrooms contain toxins that can cause serious damage to the liver.
- Be cautious
of iron. Iron, a mineral found in mean and fortified cereals, can be
toxic to the liver, especially in people who have hepatotoxicity or
infection that can cause hepatitis. Foods and cooking equipment - such
as iron skillets - high in iron should be used sparingly.
There are
a number of vitamins and minerals that have been shown to be healthful
to the liver and many nutrition experts recommend that people at risk
for liver toxicity seek out these foods at the grocery market. These include:
- Vitamin
K. Green leafy vegetables and alfalfa sprouts are a great source
of this vitamin.
- Arginine.
The liver can sometimes have a difficult time processing protein. This
can cause ammonia levels to increase in the bloodstream. Arginine, which
is found in beans, peas, lentils, and seeds, can help detoxify ammonia.
- Antioxidants.
Antioxidants work by neutralizing highly reactive, destructive compounds
called free radicals, which are produced in abundance by highly active
organs. Foods high in antioxidants include vegetables and fruits like
carrots, celery, beets, dandelion, apples, pears, and citrus. Selenium,
a powerful antioxidant, can be found in brazil nuts, brewers yeast,
kelp, brown rice, liver, molasses, seafood, wheatgerm, whole-grains,
gralic and onions.
- Methionine.
A detoxifying agent found in beans, peas, lentils, eggs, fish, garlic
onions, seeds, and meat.
What about
nutritional supplements and herbs? My health-food store stocks many products
that claim to be good for the liver.
Some complementary
therapies that have been suggested to help prevent or control liver damage
include thioctic acid, SSKT, coenzyme Q-10, glycerrhizin, milk thistle,
NAC. Astragalus, chickory, dandelion, centaury. American mandrake, and
celandine.
Unfortunately,
there is not much research data to conclude that these complementary therapies
are both safe and effective for either the prevention or treatment of
hepatotoxicity or liver damage caused by infections. Some studies have
suggested that milk thistle, a popular liver-health supplement, is safe
for people to use. We also know that NAC is used throughout Europe and
the United States to help reduce liver damage caused by acetanminophen.
It is important
to remember that simply because these complementary therapies can be purchased
without a prescription, this does not mean that they are always safe to
take. Some complementary therapies have their own side effects. It's also
clear that many complementary therapies can interact with certain anti-HIV
medications. This can further increase the risk of side effects or, quite
possibly, reduce the effectiveness of the anti-HIV medications begin used.
Be sure to check with your health care provider before starting nay complementary
therapy.
BACK
The
importance of Adhering to Your Treatment Regimen
BACK
An introduction
One of the
most important things to think about before beginning treatment for HIV
disease is your ability to take the treatments properly. This is called
"treatment adherence," and it may sound easy, but sometimes
it's not. Studies show that even doctors have enormous difficulty taking
even short-term drug regimens strictly according to the rules.
As far as
we know, anti-HIV medicine has to be taken for life. Not taking the medicine
properly can lead to "drug resistance," where HIV mutates and
becomes resistant to a drugs effect. This in turn leads to treatment failure.
Therefore, it's important to plan adherence strategies in advance.
You should
raise questions about treatment adherence with your doctor when you're
deciding what treatments to take. Different drugs have different rules
- some drugs may be taken only once a day, while others must be taken
with a high-fat meal. Because you will probably be taking several different
medications, each drug may have different rules. It's importance to know
which drug goes with which rules.
What do
I need to know to ensure good adherence?
- How many
pills of each different medicine are you supposed to take at a time?
- How many
times a day are you supposed to take each medicine, when do you take
them?
- What are
the food requirements for each different medicine?
- What should
you do if you forget a dose?
Planning
a drug regimen that works with you schedule will help to improve your
adherence. For instance, if you're often travelling from place to place
in the middle of the day, then a drug that involves a dose in the middle
of the day may give you problems. If you tend to eat at different times
each day, then drugs with strict requirements about eating may give you
a problem.
As you are
considering different treatment regimens, plan out schedules that include
the things you regularly do - such as taking your kids to school, going
to work, or eating a late dinner - and then think about how different
drug regimens might affect that schedule. For instance, let's compare
two different treatment regimens.
|
Time
of Day
|
Sustiva
+ Combivir
|
Norvir
+ Crixivan + Videx EC + Zerit
|
| 6.30
am |
Wake
up |
Wake
up, take Videx on empty stomach & 1 hour before eating |
| 7.30
am |
Breakfast
|
Breakfast,
take Norvir, Crixivan, and Zerit |
| 8.00
am |
Go
to work |
Go
to work |
| 10.30
am |
Coffee
break, take combivir with a snack |
Coffee
break |
| 12.30
pm |
Lunch |
Lunch |
| 6.00
pm |
Go
home |
Go
home |
|
Dinner |
Dinner,
take Norvir, Crixican, and Zerit |
| 10.30
pm |
Take
Combivir and Sustiva, go to bed |
Go
to bed |
You can see
from these schedules how different drug regimens have different effects
on your day.
Is there
a way to prepare for a complicated drug regimen?
Sometimes,
if you're not sure you can handle a drug regimen with a complicated schedule,
it might be wise to practice a little first before starting the actual
drugs.
This might
sound silly, but you might try to use jellybeans first! Think of it as
an experiment to see if you can adhere to a treatment regimen. For instance,
a bag of red jellybeans might represent Videx and would be taken once
a day on an empty stomach. A bag of blue jellybeans might represent Zerit,
and would be taken twice a day with or without food. A bag of green jellybeans
might represent viracept, and you'd take give green jellybeans twice a
day, with a meal or a light snack.
By following
the jellybeans regimen for a week or two, you can find out whether or
not the schedule works for you. You can also spot potential problems times,
and try to find solutions. That way, when you actually start the medicines,
you've already taken important steps to change your schedule.
Once you
think you're ready to start taking a new drug regimen, make sure to ask
your doctor any questions you still have before she or he writes the prescriptions.
One of the biggest problems with adherence is doctors who don't communicate
enough information. Make your doctor write down the instructions for taking
your medication, and read them back to her or him. It can be easy to confuse
"two pills three time a day" with "three pills two times
a day", so it's important to be sure that you understand how many
pills you're supposed to take, and how many times a day you take them.
An important
thing to know is that the times that you take the drugs are important.
In other words, if your doctor says to take a drug every twelve hours
or every eight hours, then it's important to stick pretty close to that
schedule. Taking medicine properly prevents drugs resistance - the longer
you wait to take a dose, the less there is of the previous dose in your
system to fight HIV and drug resistance.
This all
sounds to difficult, Is there an easier way?
It's just
common sense, but it's important to know that there are studies showing
that simpler treatment regimens are easier to adhere to than more complicated
regimens. In other words, a drug regimen that involves fewer pills taken
fewer times during the day may be easier to take properly than a drug
regimen that involves lots of different pills taken may times a day.
If you don't
think you can stick to a proposed drug regimen, then don't start it. Ask
your doctor about the possibility of taking an easier regimen instead.
Either way, you shouldn't start therapy until you are ready. Starting
a treatment regiment that you are very ill, it might be better to wait
until you're ready and able, or until easier treatment regimens become
available.
Once I've
started treatment, are there tools to help me stay compliant?
Yes! There
are a number of tools you can use to help you remember your doses. For
some people, a schedule on their refrigerator reminds them to take their
medicine. Others rely on electronic pillboxes this beep at the appropriate
time. Or how about a digital watch with multiple alarms.
Think about
creative ways to remind yourself to take your medicine when you're supposed
to take it. It also helps to recruit family and friends to help you remember.
Encourage the people around you to ask, "Did you take your medicine
today?" Lets face it - moral support is important!
BACK
Tuberculosis
(TB)
BACK
What is it?
Tuberculosis
(TB) is a serious respiratory disease that can be life-threatening if
not treated correctly. TB is, in fact, the world's most common disease
caused by an infectious organisms. Nearly 2 billion people in the world
are diagnosed with TB every year, a disease that is also responsible for
the deaths of nearly 3 million people annually.
In industrialized
nations such as the United States, TB was well on its way to becoming
extinct 15 years ago. With the HIV epidemic, however, TB rates started
increasing again between 1985 and 1992. Since 1992, the total number of
TB cases has once again decreased. However, in certain groups of people
in the U.S. - such as people immigrating to the United States from countries
where TB rates are very high - the TB rate is increasing. In 2000, there
were 17,531 cases of TB. Although the number of TB cases continues to
decrease, it remains one of the most common causes of sickness and death
in U.S. residents infected with HIV. In fact, TB is the number - one cause
of death of HIV-infected people across the globe.
Mycobacterium
tuberculosis, the bacteria that causes TB, is spread from one person to
another. Using microscopic drops of fluid produced by the lungs, the bacteria
can travel from the lungs of an infected person and be deposited in the
lungs of someone nearby. Once inside the lungs, the bacteria established
infection. Even though 150,000 people in the United States have been infected
with the bacteria, most people have immune systems that are healthy enough
to prevent the bacteria from ever causing TB. In people with HIV, the
immune system may eventually lose control to the bacteria, causing the
infection to spread and cause active disease. This process can take many
months or years. In other words, Mycobacterium tuberculosis can remain
alive in someone's body for many years, but may only become active - i.e.,
cause tuberculosis - once the immune system becomes damaged.
Tuberculosis
almost always causes disease of the respiratory system. In HV-positive
people, particularly those with T-cell counts below 200, the bacteria
the bacteria can also infect the lymphatic system
Compared
to HIV-negative patients with TB, HIV-positive people with the disease
may see their symptoms develop faster and with greater intensity. Treating
TB in HIV-infected patients may also need to be more aggressive in order
to clear the bacteria from the body.
What are the symptoms of TB?
Cough is
a main symptom of tuberculosis, along with night sweats, chills, weight
loss, fever, and fatigue.
How is
TB diagnosed?
To test for
Mycobacterium tuberculosis infection, a skin test called PPD can be performed
in a clinic or doctor's office. PPD stands for purified protein derivative.
It contains pieces of the bacteria and is injected directly under the
skin. If someone has been exposed to the bacteria in the past, the immune
system will immediately recognize the PPD, resulting in a firm, relatively
large bump at the site of the injection. If this reaction occurs, a person
is said to have a positive PPD.
A positive
PPD generally calls for additional testing. An X-ray of the chest is performed
to look for signs of active disease. Blood tests, along with sputum samples,
may also be sent to a lab for analysis. If the bacteria is found in these
samples, it may be tested further to see if it is resistant to nay of
the drugs commonly used to treat tuberculosis.
If someone
has a positive PPD but does not have nay signs or symptoms of active disease,
he or she is said to have latent TB infection. It is generally recommended
that people with latent TB infection begin taking drug therapy to prevent
the infection from developing further. If someone has a positive PPD and
has signs and symptoms of tuberculosis, her or she is said to have active
TB, usually involves a combination of antibiotics to treat the infection.
PPD testing
in people with HIV can be problematic. As discussed above, PPD testing
doesn't test for the presence of Mycobacterium tuberculosis, but instead
looks for signs that the immune system is currently fighting the bacteria.
In HIV-infected patients with compromised immune systems, there might
not be enough immune activity to either fight the infection or respond
to the PPD test. In other words, the bacteria might be present but is
not being recognized by the immune system and, as a result, may not show
up using PPD testing.
Because PPD
testing may not be reliable in HIV-positive people with compromised immune
systems, a diagnosis of TB might not be made until symptoms are reported
and X-rays or blood tests are performed. For some HIV-positive people
with compromised immune systems, it is better to be safe than sorry. For
example, if an HIV-positive person lives in the same house or works with
someone who has active TB and may be spreading Mycobacterium tuberculosis,
it is generally recommended that the HIV-positive person be isolated from
the person with active TB and to begin treatment.
How is
TB treated?
Treating
TB depends on the situation. As discussed in the previous section, there
are treatments for latent TB infection and treatments for active TB.
If your have
latent TB infection - that is, a positive PPD test without any signs or
symptoms of active TB- your doctor will probably prescribe one of these
two possible treatments:
Treatments
for latent TB infection (LTBI)
Isoniazid: One of the most effective antibiotics used to control
TB. It can cause liver problems and tingling/numbness of the hands and/or
feet. It is usually taken with a second drug, pyridoxine, to help prevent
peripheral neuropathy. You will probably take this drug, every day, for
nine months. Alternatively, isoniazid can be given twice a week for a
total of nine months. However, if the twice-weekly dosing schedule is
used. You will need to report to a clinic to receive your medication to
make sure that you are not missing any of your doses. Some people take
isoniazid for only six months. However, this is not recommended for people
infected with HIV.
It is very
important that you take your isoniazid and pyridoxine exactly as your
doctor tells you to and that you continue taking these medications until
your doctor tells you that it is time to stop. This is necessary to prevent
the bacteria from becoming resistant to isoniazid. If the bacteria becomes
resistant to isoniazid, you can develop active TB that is harder to treat.
- Rifampin
+ Pyrazinamide : Combining these two powerful antibiotics has been shown
to prevent LTBI from progressing to active TB, especially in HIV-positive
people. If these two drugs are taken every day, treatment for latent
TB infection can be completed in as little as two months, as oppossed
to the longer isoniazid. However, this combination of drugs was studied
in HIV-positive people before the protease inhibitors and non-nucleoside
reverse transcriptase inhibitors were approved. We now know that rifampin
can interact with many PIs and NNRTIs. Thus, if you are taking either
a PI or an NNRTI, it is recommended that you take rifabutin instead
of rifampin. But even rifabutin can interact with some anti-HIV medications.
Thus, there are rules that doctors and HIV positive people need to be
aware of :
- To be
on the safe side, it is generally recommended that HIV-positive people
who are taking either a PI or NNRTI follow the nine-month isoniazid
treatment option. The rifabutin/pyrazinamide option is best for people
who will have a hard time sticking to the strict nine-month isoniazid
course.
- Rifampin
or rifabutin should not be used by HIV-positive people who are taking
either the original version of saquinavir or the NNRTI delavirdine.
In this case, the nine-month course of isoniazid is the best option.
- The rifabutin
dose will depend on the PI or NNRTI you are taking. If you are taking
either ritonavir or lopinavir, the rifabutin dose in 150 mg twice a
day. If you are taking any of the other protease inhibitors, the correct
rifabutin dose is 150 mg once a day. If you are taking the NNRTI efavirenz,
the rifabtuin dose is 450 mg to 600 mg once a day. It is very important
that you take your rifampin and pyrazinamide exactly as your doctor
tells you to and that you continue taking these medications until your
doctor tells you that it is time to stop. This is necessary to prevent
the bacteria from becoming resistant to these two drugs. If the bacteria
becomes resistant to the drugs. You can develop active TB that is harder
to treat.
Active TB
is treated using a combination of drugs. As with HIV, in which a combination
of three antiretroviral drugs issued to help prevent resistance and keep
viral load undetectable, tuberculosis is usually treated with a combination
of four drugs to maintain control over the infection.
Some people
are infected with strains of Mycobacterium tuberculosis that are resistant
to one or more of the drugs commonly used to treat tuberculosis. This
problem a becoming more and more common in some areas of the United States,
including heavily populated cities like New York. As a result, testing
the bacteria for drug resistance as a part of diagnosing TB is sometimes
recommended.
Unfortunately,
both a confirmed diagnosis and drug-resistance testing take a long time.
Growing out Mycobacterium tuberculosis in test tubes can take more than
a week, and drug resistance testing can take as long as a month. Thus,
treatment is often started if key signs and symptoms are present.
For the first
two months of therapy, a combination of four drugs are usually prescribed,
all of which are taken by mouth:
- Isoniazid:
One of the most effective antibiotics used to control TB. It can cause
liver problems and tingling/numbness of the hands and/or feet. It is
usually taken with a second drug, pyridoxine, to help prevent peripheral
neuropathy.
- Rifampin
: Another powerful antibiotic needed to manage TB. It can cause
nausea, vomiting, diarrhea, rash, liver problems, red-orange discoloration
of body fluids, along with a decrease in white blood cells and platelets.
Rifampin can be a problem for some HIV-positive people. This is because
it interacts with many of the medications used to treat HIV. It is not
recommended that people stop their anti-HIV medications in order to
treat their TB. Instead, your doctor will probably need to change the
dose of either the rifampin or the anti-HIV medications to make sure
that you are being treated correctly without the risk of additional
side effects. If rifampin cannot be used, an alternative drug - rifabutin
- will be prescribed.
- Pyrazinamide:
The dose of this drug depends on the body weight of the person being
treated. Its side effects are similar to those of rifampin.
- Ethambutol
or streptomycin: Like pyrazinamide, the dose of these two drugs
depends on the body weight of the person being treated. Ethambutol can
cause vision problems and can cause hearing problems.
To help make
these drugs easier to take, some of them have been combined into single
pills. For example, if you take isoniazid and rifampin, your doctor can
write a prescription for Rifamate, a capsule that contains both drugs.
Two Rifamate capsules are taken twice a day, almost always in combination
with other antibiotics. If your doctor has recommended a combination of
isoniazid, rifampin, and pyrazinamide, you may be able to take Rifater,
a tablet that contains all three drugs. Depending on how much you weigh,
you will need to take four, five, or six Rifater tablets once a day, always
on an empty stomach.
If a drug-resistant
strain of Mycobacterium tuberculosis is present - either suspected by
a doctor or confirmed by testing - additional drugs are often added to
this combination. Additional drugs include: capreomycin, kanamycin, amikacin,
ethionamide, ciprofloxacin, ofloxacin, lomefloxacin, clofazimine, cycloserine,
and/or aminosalicylic acid. These drugs can also be used as a substitute
for other anti-TB drugs that cause side effects.
Here are
three ways tuberculosis can be treated using these drugs.
Standard
course of therapy:
- This is
the most common method used to treat TB, especially for HIV-positive
people. For the first eight weeks of treatment, the four drugs listed
above are used every day. After two months of therapy have been completed,
isoniazid and rifabutin are continued for an additional 16 weeks. These
drugs can be taken either every day or two or three times a week. If
you have less that 100 T-cells, experts recommend taking rifabutin every
day or three times a week. You will probably have to go to a clinic
- or have a trained medical professional watch you take your medication
every time you take your isonaizid and rifabutin during this period,
especially if you are only taking them two or three times a week.
First alternative course of therapy:
- For the
first two weeks of treatment, the four drugs listed above are used every
day. After two weeks of daily treatment have been completed, the same
four drugs are taken two times a week for an additional eight weeks.
After a total of eight weeks of four -drug treatment have been completed,
isoniazid and rifabutin are continued for an additional 16 weeks.
These drugs
can be taken either two or three times a week. Like the standard course
of therapy, you will probably have to go to a clinic - or have a trained
medical professional watch you take your medication - every time you take
your medication.
Second
alternative course of therapy:
For six months,
the four drugs listed above are used three times a week. The dose of each
drug will remain the same for the entire six months and you will need
to take all four drugs until therapy is officially completed. Like the
standard course of therapy, you will probably have to go to a clinic -
or have a trained medical professional watch you take your medication
- every time you take your medication.
It is very
important that you take your medications exactly as your doctor tells
you to and that you continue taking them until your doctor tells you that
it is time to stop. This is necessary to prevent the bacteria from becoming
resistant to the drugs. If the bacteria becomes resistant to these drugs,
the TB may return and may be more difficult to treat.
BACK
Peripheral
Neuropathy
BACK
What is it?
Peripheral
neuropathy results from injury to the peripheral nerves in the body. These
nerves carry signals between the central nervous system and the muscles,
skin, and internal organs. When peripheral neuropathy first develops,
people often report a tingling or prickling in the toes, although it can
also start in the fingers. Over time, the tingling gradually spreads up
the feet or hands and worsens into a burning, shooting, and/or throbbing
pain. People who have severe peripheral neuropathy may experience extreme
pain and may have difficulty walking, sometimes requiring the assistance
of a cane or wheelchair to move around.
People who
have peripheral neuropathy usually experience symptoms on both sides of
their bodies. In other words, peripheral neuropathy almost always occurs
in both feet and/or both hands. The sensations can be either constant
or periodic. Sometimes they may not be noticeable, while at other times
they may be extremely bothersome.
Not only
can peripheral neuropathy be physically painful, it can also have a profound
effect on qualify of life. The natural instinct to avoid or reduce pain
can prevent people from going about their regular day-to-day activities,
whether it be going up and down stairs, visiting with family or friends,
or going to work. This can cause a great deal of anxiety and can lead
to serious depression - serious emotional problems that can make life
seem altogether frustrating.
What causes
peripheral neuropathy?
There are
several possible causes of peripheral neuropathy. Direct injury, such
as a broken bone or a severe burn, can cause damage to peripheral nerves.
Certain diseases, such as diabetes, arthritis, or lupus, can also result
in nerve damage. A lack of essential vitamins and minerals, particular
vitamin B12 and E, can contribute to nerve damage. Conversely, taking
too much vitamin B6 can actually cause this condition.
HIV itself
has also been shown to cause nerve damage, usually in people with seriously
suppressed immune systems. In most HIV-positive people, however, peripheral
neuropathy is a side effect of the medicines they use - certain drugs,
including those used to treat HIV and certain AIDS - related infections,
can damage peripheral nerves and eventually lead to symptoms of neuropathy.
Some of
the HIV/AIDS drugs that can cause peripheral neuropathy include:
- ddc (Hivid)
- ddl (Videx;
Videx EC)
- d4T (Zerit)
- isoniazid
- for the prevention and treatment of tuberculosis (TB)
- vincristine
- for the treatment of Kaposi's sarcoma (KS)
- ehtambutol
- for the treatment of MAC and other bacterial infections
- metronidazole
- for the treatment of amoebas and parasitic infections
- dapsone
- for the treatment of Pneumocystis carinii pneumonia (PCP) and other
infections.
While peripheral
neuropathy is a common side effect of these drugs, this does not mean
that all people who take them will experience nerve damage or develop
symptoms of neuropathy. It's possible that people who combine these drugs
- such as d4T and ddl, two popular nucleoside analogues that are often
used together - are at a greater risk of experiencing neuropathy or developing
more severe and painful symptoms. However, this has not been the case
in some clinical trials. Many patients who combined d4T and ddl in clinical
trials were no more likely to experience peripheral neuropathy than patients
taking only one of these drugs.
What are
the symptoms of peripheral neuropathy?
Because peripheral
neuropathy is not the only nerve-related problem that can occur in HIV-positive
people, it's important that you report any noticeable symptoms to your
healthcare provider. Once you and your doctor have determined the source
of these symptoms, you can work together to figure out what to do about
it.
The symptoms
of peripheral neuropathy usually occur in the feed and/or hands:
- Numbness/insensitivity
to pain or temperature
- Extreme
sensitivity to touch
- Tingling,
prickling, or burning sensation
- Sharp
pain/cramping
- Loss of
balance/coordination
- Loss of
reflexes
- Muscle
weakness
- Noticeable
changes in the way you walk
Other
symptoms of nerve damage that you'll want to report to your doctor include:
- Noticeable
increase in the number of times you need to urinate during the day and
at night
- Difficulty
walking up and down stairs
- Frequent
stumbling or fails
- Erectile
dysfunction
Should
I stop my medicines that are causing the neuropathy?
Generally
speaking, the best way to manage peripheral neuropathy is to stop any
medications that may be causing the problem. For example, if you are taking
an anti-HIV drug regimen consisting of indinavir, 3TC, and d4T and have
symptoms of peripheral neuropathy, the most likely culprit is the d4T.
In turn, the best approach would be to switch the d4T for another nucleoside
analogue that is not known to cause peripheral neuropathy. Of course,
you should discuss this option with your healthcare provider - do not
attempt to stop any of your medications or to switch them without first
checking in with your doctor.
It can sometimes
take a few weeks or months for symptoms of peripheral neuropathy to improve
after stopping on offending drug. In some cases, symptoms can worsen before
they get better.
Unfortunately,
stopping or switching medications is not always possible. This is particularly
true for HIV-positive people whose virus is already resistant to other
currently available medications. For example, if your HIV is already resistant
to AZT, 3TC, and abacavir, using d4T or did in your regimen may be necessary
to keep your viral load low and your T-cells high. As a result, it may
be necessary to look into other options to deal with the peripheral neuropathy
directly.
I can't
switch my anti-HIV meds! What are the other options available to me?
Managing
peripheral neuropathy can be a challenge. While there are a number of
techniques available to help soothe the symptoms of this condition, we
do not yet have any treatments that can repair underlying nerve damage.
What's more, only a few of the treatments currently used to manage the
symptoms of peripheral neuropathy have been studied in clinical trials.
Thus, we don't really know which treatments are the most effective or
most likely to work for HIV-positive people suffering from peripheral
neuropathy. Figuring out which treatments will work best for you may require
a process of "trial and error." It might be possible that you
and your doctor will come upon a treatment that immediately helps to control
your symptoms. it's also possible that you'll need to try several different
treatment approaches, including combinations of different treatments,
before you find one that is truly effective. By working closely with your
doctor - letting him or her know when something is or is not being helpful
- can definitely speed up the road to pain relief and recovery.
How do
I determine which treatments are right for me?
There are
a number of medications available to help manage the pain, tingling, and
burring sensations of peripheral neuropathy. Deciding which medication
to use depends on the frequency and severity of pain. It's also important
to recognize that some medications used to treat peripheral neuropathy
have side effects of their own. Thus, there are three major factors to
consider when deciding which medications you might want to use.
- Frequency
of pain. Is the pain constant? Does the pain come and go? Does it follow
certain activities, such as walking, running, or climbing stairs? If
you're not sure when the pain kicks in, you might want to keep a seven-day
pain diary - a week before seeing your doctor, you should make a list
of all the times you feel pain, including the activities you were doing
when the pain starts, along with activities you were doing immediately
before the pain started. Knowing this will help you and your doctor
figure out which medications to use and to determine when and how you
should be using them.
- Severity
of pain. Trying to explain feelings of pain is a bit like trying to
explain what chicken tastes like- we all know what it is, but words
escape us when trying to define it. Even terms like "mild pain,"
"moderate pain," and "severe pain" - phrases that
many doctors are keen on using - can seem terribly vague. Try rating
your pain on a scale between 0 and 5, with 0 being no pain and 5 being
severe pain. The following visual guide, developed by a team of pain
specialists in 1998, has helped a number of children and adults best
explain their pain to their doctors.
- Understand
the side effects of certain medications used to treat peripheral neuropathy.
While there are certainly a number of drugs that can help reduce pain,
many of these medicines can cause side effects of their own. Some of
the more heavy-duty painkillers - narcotic medications - can help knock
out even the most severe forms of pain, but they can also cause someone
to feel extremely "drugged" or "out of it," to the
point that they can't function normally. Narcotic drugs can also be
a problem for HIV-infected people with a history of drug addiction who
are currently in recovery. Thus, it's always best to begin treatment
with the midest drugs and, if necessary, add stronger medications to
maintain a healthy balance - less pain with the least number of additional
side effects.
Okay,
so which treatments are available?
- Non-narcotic
pain relievers. These include aspirin, acetaminophen, ibuprofen, an
dnaproxen. All of these are available over-the-counter at pharmacies
and grocery stores. These medicines are often quite effective in handling
mild pain associated with peripheral neuropathy. While they can irritate
the stomach, they are not addictive and can be taken regularly to maintain
comfort. Prescription versions of these drugs - which are reimbursed
by most private and public health-insurance policies - are available
for pain that is slightly more severe.
- Tropical
medications. 5% Lidocaine gel, an anesthetic gel applied directly to
the skin, has been shown in clinical trials to be safe and effective
for HIV-positive patients dealing with painful neuropathy. Lidoderm
is now available, with a doctor's prescription, in the United States.
- Tricyclic
antidepressants. These drugs work by reducing certain chemicals in the
brain, called "neurotransmitters," that are associated with
pain and emotional distress. They are often combined with non-narcotic
pain relievers and are usually recommended for the treatment of mild-to-moderate
pain. They are also prescribed, in combination with narcotic painkillers,
to help manage severe pain.
The two most common tricyclic antidepressants are amitripytyline and
nortriptyline. It is important that low doses of these drugs be used
at first, with a slow buildup to the recommended daily doses. Amitriptyline
should be started using a dose of 25 mg or less, usually at bedtime.
Over time, the dose may be increased to 75 mg a day. With nortriptyline,
the recommended starting dose is 10 mg these times a day, building up
gradually to 30 mg three times a day. Increasing the dose gradually
is necessary to prevent certain side effects, such as dry mouth, problems
urinating, and sleepiness, that can occur with both of these drugs.
Note: some anti-HIV protease inhibitors and non-nucleoside analogues
can either increase or decrease blood levels of tricyclic antidepressants.
As a result, your doctor may want to regularly check the amount of these
drugs in your bloodstream. Be sure to discuss the possibility of drug
interactions with your doctor.
- Anticonvulsants.
Anticonvulsants are normally used to treat epilepsy, another neurologic
disorder. These drugs help calm the central nervous system, including
the part of the nervous system responsible for processing pain. While
anecdotal reports from HIV-positive patients and doctors suggest that
anticonvulsants are sometimes helpful in managing symptoms of peripheral
neuropathy, data from clinical trials are either limited or have not
shown that these drugs are, in fact, effective.
Carbamazepine
and phenytoin are two of the most common anticonvulsants used for pain
associated with peripheral neuropathy. Two new anticonvulsants, gabapentin
an dlamotrigine, have also been said to be effective treatments for
HIV-positive people suffering from neuropathy symptoms. As with the
tricyclic antidepressants, it might be necessary to increase the doses
of these drugs over the first few weeks of treatments, and to alter
your dose of these drugs if side effects occur. Some of the side effects
of anticonvulsants include loss of muscle control, rash, and decreased
blood pressure. Note: Some anti-HIV protease inhibitors and non-nucleoside
analogues can either increase or decrease blood levels of anticonvulsants.
As a result, your doctor may want to regularly check the amount of these
drugs in your bloodstream. Be sure to discuss the possibility of drug
interactions with your doctor.
- Narcotic
pain relievers. When the symptoms of peripheral neuropathy get to be
too much and don't subside with the use of the medication discussed
above, it might be necessary to use some of the more powerful narcotic
drugs to manage the pain. These drugs are usually used in combination
with non-narcotic pain relievers, along with tricyclic antidepressants
or anticonvulsants. While it's certainly safe to use narcotic pain relievers
to manage pain over the short term - even for HIV-positive people with
a history of drug addiction - they can become addictive if used on a
long-term basis. Narcotic medications can also cause nausea, vomiting,
and sleepiness. Thus, it's important to work closely with your doctor
to find a dose that helps control the pain without the addition of unwanted
side effects.
For moderate
pain, the recommended narcotic pain relievers include morphine, oxycodone,
codeine, and meperidine. For severe pain requiring heavy-duty relief,
the options are usually sustained-release morphine, methadone, and fentanyl
patches. Low doses of these drugs should be started at first and then
gradually increased until the pain is more manageable without additional
side effects. Note. Some anti-HIV protease inhibitors and non-nucleoside
analogues can either increase or decrease blood levels of narcotic pain
relievers. As a result, your doctor may want to regularly check the amount
of these drugs in your blood stream. Be sure to discuss it with your healthcare
provider.
What about
things I can do for myself to control the pain?
Whether or
not you decide to switch your anti-HIV therapies or start taking medications
to manage the symptoms of peripheral neuropathy, there are a number of
things you can do for yourself to control the pain and discomfort associated
with the side effect. Consider some of the following :
- Avoid
ill-fitting shoes. Just as shoes that are too tight can cause throbbing,
rubbing and cramping, shoes that are too loose can actually worsen pain
and may not provide enough support for already wobbly feet. The best
bet is to wear comfortable, well-fitting sneakers. Sneakers are sturdy
enough to provide support, yet flexible enough to provide the feet with
the space they needed to remain comfortable. If something a bit more
dressy is needed, whether it be for work of going out at right. It's
best to invest in a good pair of leather of shoes, and to work closely
with a knowledgeable salesperson who can work around the specific types
of pain you're dealing with.
- Keep your
feet and hand cool. Most HIV-positive people with peripheral neuropathy
say that the pain is worse during the warm summer months or at right,
when the feet are tucked away under sheets and blankets. Let your feet
breathe! If at all possible, don't wear suffocating shoes around the
house - opt for a comfortable pair of shocks or some soft slippers.
Also, don't cover your feet at right. Cool air in your bedroom can have
a numbing effect on your feet. This also helps keep the feet free of
sheets and blankets, which can sometimes be extremely painful for people
with severe peripheral neuropathy.
- Treat
your feet and hands well. Massaging your hands or feet - or having someone
message them for you - can be extremely relaxing and can increase circulation
of the blood to these extremities. Massage can also help spark endorphins.
Also try soaking painful hands and felt in cold water.
BACK
Pregnancy
& HIV
BACK
Is it
safe to be HIV+ and Pregnant?
Yes. Of course,
as is the case with the rest of HIV and its treatment, they are no absolute
certainties or across the board truths. Every woman is different.
However,
there's no data suggesting that pregnancy accelerates the rate of HIV
disease progression. HIV by itself won't stop you from having a safe pregnancy.
If you're generally healthy, get good prenatal care, and are careful to
avoid risk factors, your chances of avoiding things like premature delivery
and birth defects are not significantly different from those of your HIV-negative
counterparts.
It can be
hard to deal with the judgemental attitudes of people, including doctors,
who think that it is morally wrong for HIV-positive women to get pregnant.
The good news is that there are many strategies for dramatically reducing
the risk of passing the virus to your infant - often referred to as perinatal
or vertical transmission - which you and your doctor should be ready to
discuss. If your health-care provider isn't supportive or is being judgmental,
it's your right to find someone who will be supportive.
What are
the risks of Transmitting HIV?
An HIV-positive
pregnant woman - provided that she does not take nay anti-HIV medications
- has a 25% chance of passing HIV to her baby. However, if she takes anti-HIV
drug therapy while she is pregnant, the risk of her passing the virus
to her baby is much lower - in some cases as low as 2%.
How Does
Transmission Work?
Researchers
are not exactly sure when babies are infected with HIV during pregnancy.
It has been said that a small percentage of all babies are infected with
HIV with developing inside their mothers uteruses. However, this has not
really been proven. It is known that the vast majority of infections occur
during labor or after the body is born and is breast-fed by his or her
HIV-infected mother.
Throughout
pregnancy, a developing fetus has his or her own blood supply. In other
words, the developing fetus does not come into contact with the blood
of his or her mother. This helps protect the fetus from infections in
the mother's blood, such as HIV. However, developing fetuses do receive
nutrients and various proteins, such as immune system antibodies, from
their mothers. While a mother's HIV may not enter the fetus, her antibodies
to the virus will. These antibodies cannot harm the fetus, but will cause
the baby to test "positive" to an HIV antibodies test when he
or she is born.
At the time
of birth, a baby often comes into contact with his or her mother's blood.
If the mother's blood enters the baby's body, this is when HIV can be
transmitted.
Don't
all babies born to HIV-infected Mothers Test Positive for the Virus?
Yes, they
do. It is important to keep in mind what the HIV test is. These tests
look for antibodies to HIV, they do not look for the virus itself. Because
a fetus is exposed to his or her mother's HIV antibodies, he or she will
automatically test "positive" after birth. These antibodies
can remain in the baby's body for more than 18 months after he or she
is born.
Most hospitals
now test babies born to HIV-infected women using "PCR". This
test can be performed within a few days after delivery and looks for HIV
itself in a blood sample collected from the baby. If the test is negative,
it should be repeated within a few months after the birth to look for
HIV.
Why is
Prenatal Care So Important?
Every pregnant
woman, regardless of her HIV status, should see a doctor regularly to
receive prenatal care. Simply put, prenatal care is a specialized type
of health care designed to protect the health of both the woman and her
developing baby. Prenatal care can help all pregnant women figure out
what they should do to improve their diets and vitamin/mineral intake
and to reduce unhealthy habits such as smoking, drinking alcohol, and
doing drugs.
If a pregnant
woman does not know whether or not she's HIV positive, most prenatal care
programs now recommend HIV testing. While some states are hoping to make
HIV testing a requirement for all pregnant women, no prenatal care program
has the right to test a pregnant woman for HIV without her consent. In
New York State, the law allows for any newborn baby to be tested for HIV,
regardless of whether or not the baby's mother permits the test to be
performed.
If a pregnant
woman finds out that she is positive while she is pregnant, or knew that
she was positive before getting pregnant, prenatal care programs can help
protect her health and the health of her developing baby. Usually, a prenatal
care program calls for monthly visits to a clinic or doctor's office for
the first eight months of pregnancy. During the eighth and ninth months
of pregnancy, visits are more frequent, typically every two weeks.
Prenatal
care for women who are HIV infected may include T-cell counts and viral
loads tests, treatments to prevent AIDS-related infections, anti-HIV drug
therapy, management of drug side effects, and importance nutritional care.
HIV-positive
women might want to avoid some aspects of typical prenatal care. For example,
amniocentesis, used to test for genetic defects in the baby, is done with
a needle that passes through the mother's abdomen and into the womb. While
this test may be necessary to look for any genetic problems that a developing
baby may have, it can also increase the risk of transmitting HIV.
How can
you Reduce the Risk of Transmission?
In the following
sections, we'll discuss three topics that a pregnant woman should discuss
with her doctor that can reduce the risk of transmission to her baby anti-HIV
drug therapy. Cesarean sections, and the risk of breast-feeding.
For pregnant
women who are infected with HIV, the topic of anti-HIV drugs will most
definitely come up as a part of a prenatal care program. These drugs,
if taken correctly, can drastically reduce the amount of HIV in a mother's
blood at the time of birth. This can help reduce the chances of passing
the virus along.
Cesarean
sections - an operation in which the baby is removed through an incision
in the belly - reduces the amount of time the baby comes into contact
with his or her mother's blood and has been shown to reduce the risk of
transmitting HIV.
Since breast
milk can also transmit HIV, formula feeding, whenever clean water and
formula are available, is strongly recommended.
What about
Anti-HIV drug therapy?
Only one
anti-HIV drug - Retrovir - has been approved by the U.S. Food and Drug
Administration for the prevention of mother-to-infant HIV transmission.
According to a major study conducted several years ago about the National
Institute of Health, Retrovir therapy can reduce the risk of perinatal
transmission from 25% to approximately 8%. While there are no guarantees
that Retrovir therapy will prevent HIV from being transmitted from a mother
to her baby, if greatly reduces this chance that transmission will occur.
Retrovir
therapy during pregnancy is a three-part program :
- A standard
dose of the drug is started after the first trimester of pregnancy.
In other words, and HIV-infected pregnant would should take Retrovir
for Six months prior to giving birth to the baby. The dose is one 300
mg tablet taken twice a day.
- At the
time of delivery, whether it is by vaginal birth or C-section, higher
doses of Retrovir are administered through an intravenous line.
- A liquid
form of Retrovir is given to the baby immediately after birth and continued
for six weeks.
Is this
the Only Regimen Available?
Researchers
are still looking at other ways to use Retrovir to prevent mother-to-child
transmission. For example, one study has already demonstrated that one
does of Retrovir given either to the mother during labor or to the newborn
within 48 hours after birth, reduced the risk of transmission by more
than half.
Results from
another study suggest that giving a single dose of Virmune to both mother
and newborn infant reduces transmission rates by nearly 50%. This study
was actually conducted in African women, many of whom do not receive adequate
prenatal care. Nevirapine is current being studied in the United States
and, if used in the setting of prenatal care or in combination with other
anti-HIV drugs, the drug may prove to be very effective in reducing the
risk of mother-to-child HIV transmission.
What about
Combination Anti-HIV Therapy?
More and
more women are taking combinations of anti-HIV therapies to keep themselves
healthier and alive longer. Effective combination therapy can lower viral
load to below the limits of detection and ease the pressure on the immune
system. Not only are the effects of combination therapy good for the mother,
they have also been said to further reduce the risk of transmitting HIV.
Given what
is known about Retrovir, it is recommended that any combination of drugs
used during pregnancy include this drug.
Figuring
out whether or not to start combination therapy - or remain on combination
therapy - is a difficult decision for all HIV-infected pregnant women.
If you are HIV-positive and pregnant, here are some questions you should
consider discussion with your doctor before starting combination therapy.
How have
you been feeling?
What was
your most recent T-cell count?
What was
your most recent viral load?
Does your
doctor think that you/re at risk for developing HIV-related illnesses?
Of course,
HIV-infected pregnant women will want to consider how the drugs they're
thinking of taking might affect the baby. There's new research being produce
all the time about the safety and tolerability of different medications
for pregnant women and their developing babies.
What about
the Potential side effects of Combination Therapy?
Anybody who
is HIV-positive and taking an anti-HIV drug combination faces the risk
of side effects. HIV-infected pregnant women are no different. Side effects
include metabolic changes and lipodystrophy, which can cause an increase
in blood levels of flats and sugars. By itself, pregnancy is a risk factor
for elevated glucose levels. It's not yet known if anti-HIV medications
increase the risk of these metabolic problems occurring in pregnant women.
Some anti-HIV
drugs can cause liver damage, such as increases in the liver enzyme bilirubin.
Too much of this enzyme can harm a fetus. While most HIV-infected people
taking a protease inhibitor only experience mild increases in this enzyme,
pregnant women taking these drugs - especially the protease inhibitor
Crixivan - should be extra careful and have their bilirubin levels checked
regularly.
Another possible
side effect of combination therapy is pre-term delivery. In early clinical
trials, some women who used a combination of anti-HIV drugs that included
protease inhibitors gave birth to their babies earlier than they should
have. This can cause health problems for the baby. However, a number of
studies conducted in recent years have not found that HIV-positive women
receiving combination therapy are any more likely than other women to
give birth to pre-term babies. But there is a risk.
There has
also been concern about the drug efavirenz Sustiva. Pregnant monkeys who
received this drug gave birth to babies with deformities, some of them
quite severe. However, a number of HIV-infected pregnant women have used
this drug and, to date, none have given birth to babies with the same
deformities seen in the monkey experiments. Again, there is a risk of
damage and many experts do not recommend this drug for HIV-infected pregnant
women.
Some drugs,
especially the nucleoside analogues, can damage the mitochondria- the
tiny "powerhouses" inside cells that provide cells with energy.
Cells that contain too many severely damaged mitochondria must resort
to an abnormal type of energy production that doesn't rely on the mitochondria.
Lactic acid is the chemical byproduct of this sort of abnormal energy
production. If too much lactic acid builds up in the body, serious illness
can occur, including fatigue, nausea/vomiting, painful inflammation of
the pancrease, and liver damage.
Severe cases
of lactic acidosis can be deadly. The U.S. food and drug administration
ahs issued an important warning that HIV-positive women should not take
Zerit and Videx or Videx EC at the same time if they are pregnant. Some
pregnant women who took these drugs together developed lactic acidosis,
some of whom died. It is not clear if any of the other nucleoside analogues
cause lactic acidosis in women or mitochondiral damage in babies born
to mothers taking these drugs. Fortunately, Retrovir has been studied
for many years in pregnant women and babies and has not been shown to
cause any of these problems.
What if
I Become Pregnant While I'm on Therapy?
If you become
pregnant while you're receiving anti-HIV drug therapy, you have several
options. The first is to stay with your combination. If it's working -
that is, it's keeping your viral load at or near undetectable levels and
doesn't cause you lots of side effects - staying on therapy might be a
good option. A recent review of roughly 3,500 pregnancies in HIV-positive
women found that the rates of "adverse events" - complications
during or after pregnancy- weren't increased in women who took combination
therapy.
You may also
consider stopping therapy for the first three months of your pregnancy
to minimize fetal exposure to drugs during the earliest stages of development.
After the first three months, you can restart your old regimen. Or, you
may choose to stay off therapy altogether for the remainder of your pregnancy.
No matter what, you should strongly consider taking AZT to reduce the
risk of transmission.
If you've
been having a hard time taking all your pills, or if the side effects
are really bothering you, it may be a good idea to stop, at least for
the beginning of your pregnancy. There's no way of knowing how you'll
feel while you're pregnant - morning sickness on top of daily drug-related
nausea could be the last straw. Stopping a complicated drug regimen also
minimizes the risk of developing drug -resistant virus, which can limit
your subsequent treatment options, and could even get passed on to your
baby.
A word of
caution: Accidents happen. Some oral contraceptives - birth-control pills
- do not mix well with some anti-HIV drugs. For example, efavirenz can
increase blood levels of oral contraceptives and, in turn, may increases
the side effects of the hormones found in these pills. The protease inhibitors
ritonavir and nelfinavir can decrease the amount of oral contraceptives
in the blood. This can increase the chance of becoming pregnant. If you're
trying to avoid pregnancy, it might be best to use a barrier method -
e.g., condoms, diaphragm, etc - while using anti-HIV drugs.
Should
HIV+Pregnant Women have drug - resistance Tests?
Seeing that
the goal of anti-HIV drug therapy is to reduce viral load to undetectable
levels - preferably to less than 50 copies/mL - all HIV-positive pregnant
women should consider having a drug resistance test if their viral load
becomes detectable while receiving therapy. These tests can determine
which drugs are no longer working and help figure out which drugs to switch
to. In this way, drug-resistance tests are valuable for anyone who is
receiving anti-HIV drug therapy, not just pregnant women.
What About
Cesarean Sections?
Cesarean
Section - often called a "C-section" - is a type of surgery
that has been said to greatly reduce an HIV-positive woman's risk of passing
along the virus to her baby at the time of birth. However, it is still
not known if C-sections are nay more effective than taking a powerful
andit-HIV drug combination in reducing this risk. It is also not known
if a woman who takes a powerful anti-HIV drug combination and has a C-section
has a lower chance of passing along the virus to her baby than a woman
who takes anti-HIV drugs and has a vaginal delivery.
To perform
a C-section, a needle is inserted into the woman's spine and injected
with morphine. This causes numbness from the waist down, allowing the
doctor to make a long incision under the bellybutton to remove the baby.
There is
also a surgical procedure called a "bloodless C-section". This
type of surgery goes a sleep further than regular C-sections. In a bloodless
C-section, the blood vessels near the womb are weided, or "cauterized",
using a laser to prevent them from bleeding. This procedure lowers the
risk that the baby will come into contact with his or her mother's blood.
Some experts
do not like the idea of C-sections. Because C-sections are a type of surgery,
there are risks of infection and other complications. It is also important
to remember that a combination of anti-HIV-drugs - which may include AZT
plus two other drugs - might do a better job of stopping transmission,
without even needing a C-section. According to some studies, in HIV-positive
pregnant women who have an undetectable viral load at the time of birth,
the risk of delivering a baby infected with the virus is less than 2%.
Again, it is not known if C-sections reduce this risk any further.
Many doctors
- particularly obstetricians and gynecologists - recommend to their HIV-infected
pregnant patients that they have a C-section to deliver their babies.
However, it is important that HIV-infected pregnant women.
C-sectors are an option, not a requirement. No patient should ever
be forced to have a surgical procedure. An HIV-infected pregnant woman
has the right to refuse a C-section.
If a doctor has recommended a C-section, he or she should explain
the procedure and discuss the possible benefits and the potential risks.
What about
breast - feeding?
Breast milk
carries HIV too, and breast-feeding adds considerable risk of transmission.
As with transmission via blood, there's some indication that risk increases
along with viral load. So far, research shows that the risk of breast
milk transmission is highest in the first six months of life. However,
there's no threshold or time point beyond which it becomes absolutely
safe to breast - feed.
Wherever
clean water and formula are available. It's recommended that HIV-positive
women exclusively formula feed their infants.
In the past
year, a handful of studies have also looked at breast milk pasteurization,
a procedure that allows women to express their breast milk and treat it
themselves so that it becomes safe for their infants to drink. Right now,
these studies have been done in resource-poor settings; your doctor may
have more information about this strategy.
What Else
Can I Do?
What's good
advice for people with HIV is great advice for pregnant women: take good
care of yourself and gets lots of support. Support can mean a lot of different
things, but it definitely means having someone to talk to someone who
can listen, who won't judge you and your decisions, and will help you
figure out what to do when things get murky. This could be a counselor,
family member, partner or friend. Ideally, it will be a collection of
these folks.
Look for
a team of people to work with you: a good OB/GYN and an HIV specialist,
and possibly a case manger who will help you navigate whatever benefits
and services you need during and after your pregnancy. Find a nutritionist
who can help you satisfy your cravings - and will also help you to eat
right. And talk, talk, talk to other positive mothers about their experiences.
Be sure you have a plan for yourself and the baby so you're prepared after
the birth.
Taking great
care of yourself while you're pregnant is important - but it's just as
important that you pay attention to yourself after your baby is born.
Lots of women have trouble keeping to their pill schedules once the whirlwind
of nursing and feeding and cleaning begins. It's fine to stop all your
drugs. Just discuss it with your doctor first. Or, you may want to switch
to a simpler regimen. Just remember, your health matters too. Look for
ways to make things more manageable - for instance, some clinics are set
up so that you and your baby can have doctor's visits on the same day.
Most of all,
do whatever you need to feel good about yourself. Trust your instincts.
Take time to pamper yourself. You, and your baby, are worth it.
BACK
|